Submitted URL: https://dougallgpt.com/short/nl-external?dp=529-c274006f-5df3-4b69-b70f-c021a09acbb0&nlSite=dougallgpt_smartvite&eventI...
Effective URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell...
Submission: On June 02 via api from BE — Scanned from DE

Summary

This website contacted 14 IPs in 5 countries across 10 domains to perform 57 HTTP transactions. The main IP is 104.18.10.172, located in and belongs to CLOUDFLARENET, US. The main domain is dougallmd.com.
TLS certificate: Issued by GTS CA 1P5 on May 3rd 2024. Valid for: 3 months.
This is the only time dougallmd.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
3 12 104.18.18.240 13335 (CLOUDFLAR...)
2 2 2600:9000:211... 16509 (AMAZON-02)
6 2a00:1450:400... 15169 (GOOGLE)
2 2.17.147.219 20940 (AKAMAI-ASN1)
4 2602:816:5001... 54113 (FASTLY)
2 104.18.19.240 13335 (CLOUDFLAR...)
2 2606:4700::68... 13335 (CLOUDFLAR...)
6 185.221.87.23 54113 (FASTLY)
2 16 104.18.10.172 13335 (CLOUDFLAR...)
2 2a00:1450:400... 15169 (GOOGLE)
4 52.205.46.52 14618 (AMAZON-AES)
2 108.138.36.76 16509 (AMAZON-02)
2 2606:4700::68... 13335 (CLOUDFLAR...)
1 2606:4700::68... 13335 (CLOUDFLAR...)
57 14
Apex Domain
Subdomains
Transfer
19 dougallmd.com
dougallmd.com
phnx.dougallmd.com
a.dougallmd.com
c-phnx.dougallmd.com
c-neml.dougallmd.com
1 MB
16 dougallgpt.com
dougallgpt.com
phnx.dougallgpt.com
a.dougallgpt.com
c-phnx.dougallgpt.com
c-neml.dougallgpt.com
1 MB
6 nr-data.net
bam.eu01.nr-data.net — Cisco Umbrella Rank: 10131
3 KB
6 googleapis.com
fonts.googleapis.com — Cisco Umbrella Rank: 33
5 KB
4 imperium.com
rvid.imperium.com — Cisco Umbrella Rank: 50254
4 KB
4 newrelic.com
js-agent.newrelic.com — Cisco Umbrella Rank: 636
110 KB
2 neml.io
api.neml.io
2 KB
2 gstatic.com
fonts.gstatic.com
92 KB
2 aimatch.com
content.aimatch.com — Cisco Umbrella Rank: 72938
5 KB
2 phnxml.io
api.phnxml.io — Cisco Umbrella Rank: 375761
3 KB
57 10
Domain Requested by
8 phnx.dougallmd.com dougallmd.com
8 dougallgpt.com 3 redirects dougallgpt.com
6 dougallmd.com 2 redirects dougallgpt.com
dougallmd.com
6 bam.eu01.nr-data.net dougallgpt.com
dougallmd.com
6 fonts.googleapis.com dougallgpt.com
dougallmd.com
4 rvid.imperium.com dougallgpt.com
dougallmd.com
4 js-agent.newrelic.com dougallgpt.com
dougallmd.com
3 c-phnx.dougallmd.com dougallmd.com
3 c-phnx.dougallgpt.com dougallgpt.com
2 api.neml.io dougallgpt.com
dougallmd.com
2 fonts.gstatic.com fonts.googleapis.com
2 a.dougallgpt.com dougallgpt.com
a.dougallgpt.com
2 phnx.dougallgpt.com dougallgpt.com
2 content.aimatch.com dougallgpt.com
dougallmd.com
2 api.phnxml.io 2 redirects
1 c-neml.dougallmd.com dougallmd.com
1 a.dougallmd.com dougallmd.com
1 c-neml.dougallgpt.com dougallgpt.com
57 18

This site contains no links.

Subject Issuer Validity Valid
dougallgpt.com
GTS CA 1P5
2024-05-31 -
2024-08-29
3 months crt.sh
upload.video.google.com
WR2
2024-05-13 -
2024-08-05
3 months crt.sh
content.aimatch.com
R3
2024-05-09 -
2024-08-07
3 months crt.sh
js-agent.newrelic.com
GlobalSign Atlas R3 DV TLS CA 2024 Q1
2024-03-21 -
2025-04-22
a year crt.sh
phnx.dougallgpt.com
GTS CA 1P5
2024-04-20 -
2024-07-19
3 months crt.sh
a.dougallgpt.com
GTS CA 1P5
2024-05-23 -
2024-08-21
3 months crt.sh
c-phnx.dougallgpt.com
GTS CA 1P5
2024-04-11 -
2024-07-10
3 months crt.sh
*.eu01.nr-data.net
DigiCert TLS RSA SHA256 2020 CA1
2023-11-03 -
2024-10-01
a year crt.sh
c-neml.dougallgpt.com
GTS CA 1P5
2024-04-10 -
2024-07-09
3 months crt.sh
dougallmd.com
GTS CA 1P5
2024-05-03 -
2024-08-01
3 months crt.sh
*.gstatic.com
WR2
2024-05-13 -
2024-08-05
3 months crt.sh
*.imperium.com
Amazon RSA 2048 M02
2023-12-24 -
2025-01-21
a year crt.sh
api.neml.io
Amazon RSA 2048 M02
2024-01-29 -
2025-02-26
a year crt.sh

This page contains 1 frames:

Primary Page: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Frame ID: 26B95A7AD268FB96CD318B8C4F2F0314
Requests: 50 HTTP requests in this frame

Screenshot

Page Title

Dougall MD | Eftilagimod Improves Efficacy of Pembrolizumab in First-Line Treatment of Non-Small-Cell Lung Cancer

Page URL History Show full URLs

  1. https://dougallgpt.com/short/nl-external?dp=529-c274006f-5df3-4b69-b70f-c021a09acbb0&nlSite=dougall... HTTP 302
    https://dougallgpt.com/short/nl-external?interactionId=P9ZxVFXfdlR9f9yRftjqExx6EdL3emVB04EOocIrO_qX... HTTP 301
    https://api.phnxml.io/v2/nl/urlresolver?interactionId=P9ZxVFXfdlR9f9yRftjqExx6EdL3emVB04EOocIrO_qX... HTTP 301
    https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5m... HTTP 302
    https://dougallgpt.com/nl-external?interactionId=yoSHYsdDdtgLdlR6c8nf5Os0-P55l_TpeNts6QMSPvXoGYF-H4... Page URL
  2. https://dougallmd.com/omni/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-tr... HTTP 302
    https://dougallmd.com/omni/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-tr... HTTP 301
    https://api.phnxml.io/v2/auth/token/omni?siteId=530&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaX... HTTP 301
    https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatme... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • <link[^>]* href=[^>]+fonts\.(?:googleapis|google)\.com

Overall confidence: 100%
Detected patterns
  • piwik\.js|piwik\.php

Page Statistics

57
Requests

98 %
HTTPS

50 %
IPv6

10
Domains

18
Subdomains

14
IPs

5
Countries

3173 kB
Transfer

9247 kB
Size

7
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. https://dougallgpt.com/short/nl-external?dp=529-c274006f-5df3-4b69-b70f-c021a09acbb0&nlSite=dougallgpt_smartvite&eventId=31425&campaignId=1402&siteId=1020&brandId=154&source=DGPTLessons&dest=article&fbId=5676151&external=true&pos=4 HTTP 302
    https://dougallgpt.com/short/nl-external?interactionId=P9ZxVFXfdlR9f9yRftjqExx6EdL3emVB04EOocIrO_qXYeFvKq21Hw%3D%3D&dp=529-c274006f-5df3-4b69-b70f-c021a09acbb0&nlSite=dougallgpt_smartvite&eventId=31425&campaignId=1402&siteId=1020&brandId=154&source=DGPTLessons&dest=article&fbId=5676151&external=true&pos=4 HTTP 301
    https://api.phnxml.io/v2/nl/urlresolver?interactionId=P9ZxVFXfdlR9f9yRftjqExx6EdL3emVB04EOocIrO_qXYeFvKq21Hw%3D%3D&dp=529-c274006f-5df3-4b69-b70f-c021a09acbb0&nlSite=dougallgpt_smartvite&eventId=31425&campaignId=1402&siteId=1020&brandId=154&source=DGPTLessons&dest=article&fbId=5676151&external=true&pos=4&interactionId=P9ZxVFXfdlR9f9yRftjqExx6EdL3emVB04EOocIrO_qXYeFvKq21Hw%3D%3D&pwId=146&property=dougallgpt&domain=dougallgpt.com&path=%2Fnl-external&somDomain=api.phnxml.io&somUri=%2Fv1%2Fsom%2Fclick HTTP 301
    https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=31425&nl_campaignid=1402&profileId=339331579&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=4&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&source=DGPTLessons HTTP 302
    https://dougallgpt.com/nl-external?interactionId=yoSHYsdDdtgLdlR6c8nf5Os0-P55l_TpeNts6QMSPvXoGYF-H4L2fg%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=31425&nl_campaignid=1402&profileId=339331579&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=4&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&source=DGPTLessons Page URL
  2. https://dougallmd.com/omni/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80&article_id=5676151&article_title=Eftilagimod%20Improves%20Efficacy%20of%20Pembrolizumab%20in%20First-Line%20Treatment%20of%20Non-Small-Cell%20Lung%20Cancer&source=dougallgpt HTTP 302
    https://dougallmd.com/omni/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80&article_id=5676151&article_title=Eftilagimod%20Improves%20Efficacy%20of%20Pembrolizumab%20in%20First-Line%20Treatment%20of%20Non-Small-Cell%20Lung%20Cancer&source=dougallgpt HTTP 301
    https://api.phnxml.io/v2/auth/token/omni?siteId=530&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80&url=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3FinteractionId%3DDDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%253D%253D%26dp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80%26article_id%3D5676151%26article_title%3DEftilagimod%2BImproves%2BEfficacy%2Bof%2BPembrolizumab%2Bin%2BFirst-Line%2BTreatment%2Bof%2BNon-Small-Cell%2BLung%2BCancer%26source%3Ddougallgpt%26interactionId%3DDDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%253D%253D&source=dougallgpt&interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA==&idhBrandId=150 HTTP 301
    https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 0
  • https://dougallgpt.com/short/nl-external?dp=529-c274006f-5df3-4b69-b70f-c021a09acbb0&nlSite=dougallgpt_smartvite&eventId=31425&campaignId=1402&siteId=1020&brandId=154&source=DGPTLessons&dest=article&fbId=5676151&external=true&pos=4 HTTP 302
  • https://dougallgpt.com/short/nl-external?interactionId=P9ZxVFXfdlR9f9yRftjqExx6EdL3emVB04EOocIrO_qXYeFvKq21Hw%3D%3D&dp=529-c274006f-5df3-4b69-b70f-c021a09acbb0&nlSite=dougallgpt_smartvite&eventId=31425&campaignId=1402&siteId=1020&brandId=154&source=DGPTLessons&dest=article&fbId=5676151&external=true&pos=4 HTTP 301
  • https://api.phnxml.io/v2/nl/urlresolver?interactionId=P9ZxVFXfdlR9f9yRftjqExx6EdL3emVB04EOocIrO_qXYeFvKq21Hw%3D%3D&dp=529-c274006f-5df3-4b69-b70f-c021a09acbb0&nlSite=dougallgpt_smartvite&eventId=31425&campaignId=1402&siteId=1020&brandId=154&source=DGPTLessons&dest=article&fbId=5676151&external=true&pos=4&interactionId=P9ZxVFXfdlR9f9yRftjqExx6EdL3emVB04EOocIrO_qXYeFvKq21Hw%3D%3D&pwId=146&property=dougallgpt&domain=dougallgpt.com&path=%2Fnl-external&somDomain=api.phnxml.io&somUri=%2Fv1%2Fsom%2Fclick HTTP 301
  • https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=31425&nl_campaignid=1402&profileId=339331579&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=4&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&source=DGPTLessons HTTP 302
  • https://dougallgpt.com/nl-external?interactionId=yoSHYsdDdtgLdlR6c8nf5Os0-P55l_TpeNts6QMSPvXoGYF-H4L2fg%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=31425&nl_campaignid=1402&profileId=339331579&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=4&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&source=DGPTLessons
Request Chain 55
  • https://p-dgan.dougallmd.com/dgan/bserverj/b1/hint=x/DSPID=/property=dougallmd/mid=101364469/emailid=7651829/personid=101364469/channel=website/size=520x150/geography=be/prof=12/spec=55/viewid=1013644695301717330901193/random=19908/pid=29908/CampaignID=1/interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA==/zone=articlepage/tags=CND3843,CND0396,CND2861,CND4281,CND2061,CND4356,CND3665,CND5557,CND6427,DRG07177,DRG10740,DRG04819 HTTP 301
  • https://api.phnxml.io/v2/content/dgan?originalQueryString=&requestId=5c044kjB-rDroeCFN3LG6SxZm5poEqBcB1n97yFYj4iVTw7SPEuLUA%3D%3D&requestPath=%2Fdgan%2Fbserverj%2Fb1%2Fhint%3Dx%2FDSPID%3D%2Fproperty%3Ddougallmd%2Fmid%3D101364469%2Femailid%3D7651829%2Fpersonid%3D101364469%2Fchannel%3Dwebsite%2Fsize%3D520x150%2Fgeography%3Dbe%2Fprof%3D12%2Fspec%3D55%2Fviewid%3D1013644695301717330901193%2Frandom%3D19908%2Fpid%3D29908%2FCampaignID%3D1%2FinteractionId%3DDDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D%2Fzone%3Darticlepage%2Ftags%3DCND3843%2CCND0396%2CCND2861%2CCND4281%2CCND2061%2CCND4356%2CCND3665%2CCND5557%2CCND6427%2CDRG07177%2CDRG10740%2CDRG04819&timestamp=1717330901982&referer=https%3A%2F%2Fdougallmd.com%2F&userAgent=Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36

57 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
nl-external
dougallgpt.com/
Redirect Chain
  • https://dougallgpt.com/short/nl-external?dp=529-c274006f-5df3-4b69-b70f-c021a09acbb0&nlSite=dougallgpt_smartvite&eventId=31425&campaignId=1402&siteId=1020&brandId=154&source=DGPTLessons&dest=articl...
  • https://dougallgpt.com/short/nl-external?interactionId=P9ZxVFXfdlR9f9yRftjqExx6EdL3emVB04EOocIrO_qXYeFvKq21Hw%3D%3D&dp=529-c274006f-5df3-4b69-b70f-c021a09acbb0&nlSite=dougallgpt_smartvite&eventId=3...
  • https://api.phnxml.io/v2/nl/urlresolver?interactionId=P9ZxVFXfdlR9f9yRftjqExx6EdL3emVB04EOocIrO_qXYeFvKq21Hw%3D%3D&dp=529-c274006f-5df3-4b69-b70f-c021a09acbb0&nlSite=dougallgpt_smartvite&eventId=31...
  • https://dougallgpt.com/nl-external?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYz...
  • https://dougallgpt.com/nl-external?interactionId=yoSHYsdDdtgLdlR6c8nf5Os0-P55l_TpeNts6QMSPvXoGYF-H4L2fg%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ...
31 KB
11 KB
Document
General
Full URL
https://dougallgpt.com/nl-external?interactionId=yoSHYsdDdtgLdlR6c8nf5Os0-P55l_TpeNts6QMSPvXoGYF-H4L2fg%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=31425&nl_campaignid=1402&profileId=339331579&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=4&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&source=DGPTLessons
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.18.240 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
0a4c3011ac68cf553656e458309b974e55c6f736c2c658b7688f72d4e01aaf3e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options DENY

Request headers

Accept-Language
de-DE,de;q=0.9;q=0.9
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

alt-svc
h3=":443"; ma=86400
cf-cache-status
DYNAMIC
cf-ray
88d7677b3d1503a0-FRA
content-encoding
gzip
content-type
text/html
date
Sun, 02 Jun 2024 12:21:37 GMT
last-modified
Thu, 30 May 2024 19:40:45 GMT
server
cloudflare
strict-transport-security
max-age=31536000; includeSubDomains; preload
vary
Accept-Encoding
via
1.1 319f376925908156190f5fc160137b42.cloudfront.net (CloudFront)
x-amz-cf-id
tL8uiZT3V62Smc4jeyhg1pfxeMoT_Wi5Ks2uYt3yqfMDhqvb0Ex-YA==
x-amz-cf-pop
FRA60-P3
x-amz-id-2
KKYS2QMOokLj7puh8rVBf/ARM9+hCdLgxM/HyGbtIofuxs9uIVwt4OVTkF90nBUpo62IOnNEqNI=
x-amz-request-id
Y44V34VCPYZF8SP9
x-amz-server-side-encryption
AES256
x-amz-version-id
2G.aukpRevhP2_aUeW.gxqDnYwOEzqYL
x-cache
Miss from cloudfront
x-content-type-options
nosniff
x-frame-options
DENY

Redirect headers

alt-svc
h3=":443"; ma=86400
cf-cache-status
DYNAMIC
cf-ray
88d7677a7bad03a0-FRA
content-length
0
date
Sun, 02 Jun 2024 12:21:37 GMT
location
https://dougallgpt.com/nl-external?interactionId=yoSHYsdDdtgLdlR6c8nf5Os0-P55l_TpeNts6QMSPvXoGYF-H4L2fg%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=31425&nl_campaignid=1402&profileId=339331579&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=4&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&source=DGPTLessons
server
cloudflare
strict-transport-security
max-age=31536000; includeSubDomains; preload
via
1.1 319f376925908156190f5fc160137b42.cloudfront.net (CloudFront)
x-amz-cf-id
yoSHYsdDdtgLdlR6c8nf5Os0-P55l_TpeNts6QMSPvXoGYF-H4L2fg==
x-amz-cf-pop
FRA60-P3
x-cache
LambdaGeneratedResponse from cloudfront
x-content-type-options
nosniff
css
fonts.googleapis.com/
4 KB
731 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Inter:400,700
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?interactionId=yoSHYsdDdtgLdlR6c8nf5Os0-P55l_TpeNts6QMSPvXoGYF-H4L2fg%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=31425&nl_campaignid=1402&profileId=339331579&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=4&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&source=DGPTLessons
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
5848917b31a4f0f69ab224f717c6290d8771b9a2a374d1c024b6b8f218b3ad99
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://dougallgpt.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

strict-transport-security
max-age=31536000
date
Sun, 02 Jun 2024 12:21:37 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
0
last-modified
Sun, 02 Jun 2024 12:21:37 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Sun, 02 Jun 2024 12:21:37 GMT
css
fonts.googleapis.com/
2 KB
964 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Raleway
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?interactionId=yoSHYsdDdtgLdlR6c8nf5Os0-P55l_TpeNts6QMSPvXoGYF-H4L2fg%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=31425&nl_campaignid=1402&profileId=339331579&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=4&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&source=DGPTLessons
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
cdbcbb6ab7680b6f7ee6f09ff2a54b0e8e3eb6e758efb1c0a7fe5e71fb0da118
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://dougallgpt.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

strict-transport-security
max-age=31536000
date
Sun, 02 Jun 2024 12:21:37 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
0
last-modified
Sun, 02 Jun 2024 11:33:45 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Sun, 02 Jun 2024 12:21:37 GMT
main.c2d4dc5b.js
dougallgpt.com/static/js/
3 MB
692 KB
Script
General
Full URL
https://dougallgpt.com/static/js/main.c2d4dc5b.js
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?interactionId=yoSHYsdDdtgLdlR6c8nf5Os0-P55l_TpeNts6QMSPvXoGYF-H4L2fg%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=31425&nl_campaignid=1402&profileId=339331579&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=4&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&source=DGPTLessons
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.18.240 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
69625419cbbd8cba9d1a11593839fef562050c33b6b6734d0c9fefc68a50a413
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options DENY

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://dougallgpt.com/nl-external?interactionId=yoSHYsdDdtgLdlR6c8nf5Os0-P55l_TpeNts6QMSPvXoGYF-H4L2fg%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=31425&nl_campaignid=1402&profileId=339331579&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=4&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&source=DGPTLessons
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 12:21:37 GMT
x-amz-version-id
PZO3C7BlcygEcVb2qGCt8qJ_9x2Y3ohE
content-encoding
gzip
cf-cache-status
HIT
via
1.1 3296b04068551f925d5fafd1b785ff30.cloudfront.net (CloudFront)
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-request-id
A5A2SYPK7GQKTDVC
x-amz-cf-pop
FRA60-P3
x-amz-server-side-encryption
AES256
x-cache
Miss from cloudfront
alt-svc
h3=":443"; ma=86400
x-amz-id-2
QXO4dI47wBSr2mGC7l/YCOVmKRkguz+Fs4K2dfOy5qIMx16c8gyKnt69zIrMbZdFf5gF7FmeMBo=
last-modified
Thu, 30 May 2024 19:40:45 GMT
server
cloudflare
etag
W/"781c3b83cfc83a34ef22b59b25705af7"
vary
Accept-Encoding
x-frame-options
DENY
content-type
text/javascript
cache-control
public, max-age=14400
cf-ray
88d7677d591403a0-FRA
x-amz-cf-id
x6tKmfLwIaeAdqlVI_leqBmUkzwA4DJ_4tJ8V7smZfbl-LNZ6uAc_A==
expires
Sun, 02 Jun 2024 16:21:37 GMT
main.a6b252db.css
dougallgpt.com/static/css/
68 KB
13 KB
Stylesheet
General
Full URL
https://dougallgpt.com/static/css/main.a6b252db.css
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?interactionId=yoSHYsdDdtgLdlR6c8nf5Os0-P55l_TpeNts6QMSPvXoGYF-H4L2fg%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=31425&nl_campaignid=1402&profileId=339331579&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=4&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&source=DGPTLessons
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.18.240 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
d08ff424f86d18d64244e8d6c260c6eb06db2dac734549795fb6ea2d7276a0b5
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options DENY

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://dougallgpt.com/nl-external?interactionId=yoSHYsdDdtgLdlR6c8nf5Os0-P55l_TpeNts6QMSPvXoGYF-H4L2fg%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=31425&nl_campaignid=1402&profileId=339331579&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=4&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&source=DGPTLessons
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 12:21:37 GMT
x-amz-version-id
CoFuH4yhspd_HKJdkJLAPRpV4aAduDrv
content-encoding
gzip
cf-cache-status
REVALIDATED
via
1.1 400be015a105355a3fb16d2aa2a6d926.cloudfront.net (CloudFront)
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-request-id
YBFAV9Z7BMTZ86AJ
x-amz-cf-pop
AMS1-P3
x-amz-server-side-encryption
AES256
x-cache
Miss from cloudfront
alt-svc
h3=":443"; ma=86400
x-amz-id-2
pxX6Cee2DQR6JD8x11NW4kZciYFB2foETf9zm+nEBMihsFUtP+AdllIpzu5S1h0nLiY+57P1gBM=
last-modified
Fri, 10 May 2024 16:44:44 GMT
server
cloudflare
etag
W/"65e87d89ad55d540ab061d05271f1af5"
vary
Accept-Encoding
x-frame-options
DENY
content-type
text/css
cache-control
public, max-age=14400
cf-ray
88d7677cd85403a0-FRA
x-amz-cf-id
Tx71jX3ABqYYU8jqFFpdO7H3yhBBff64yqdOJ_iyFBHrRFKonpiXJw==
expires
Sun, 02 Jun 2024 16:21:37 GMT
sasia.min.js
content.aimatch.com/js/sasia/v1/
6 KB
2 KB
Script
General
Full URL
https://content.aimatch.com/js/sasia/v1/sasia.min.js
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?interactionId=yoSHYsdDdtgLdlR6c8nf5Os0-P55l_TpeNts6QMSPvXoGYF-H4L2fg%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=31425&nl_campaignid=1402&profileId=339331579&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=4&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&source=DGPTLessons
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2.17.147.219 Prague, Czech Republic, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
a2-17-147-219.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
080b836d73ad378365492df072f69365eb76bca3ad7fe715d854b5cf012a493f

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://dougallgpt.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

x-amz-version-id
null
content-encoding
gzip
date
Sun, 02 Jun 2024 12:21:37 GMT
last-modified
Tue, 16 Feb 2016 15:21:55 GMT
server
AmazonS3
x-amz-request-id
FG19XY1728KCCSQ0
etag
"c1a192142497cfc2d2def7217929e22b"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
max-age=3600
accept-ranges
bytes
content-length
2231
x-amz-id-2
DpxXrcqgZocFmMmQl1eJZTAz1r0a3fslvPeH8LX6ip+5fHjQDH7B0/7WQot9AUwx5TaAqIgOfok=
expires
Sun, 02 Jun 2024 13:21:37 GMT
css2
fonts.googleapis.com/
5 KB
717 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css2?family=EB+Garamond:wght@400;600&display=swap
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/static/css/main.a6b252db.css
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
14d0333bd3bc84f7662a5956639e474a4d5db164fb2e43c8aa4097fca9eeed0c
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://dougallgpt.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

strict-transport-security
max-age=31536000
date
Sun, 02 Jun 2024 12:21:37 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
0
last-modified
Sun, 02 Jun 2024 12:21:37 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Sun, 02 Jun 2024 12:21:37 GMT
nr-loader-spa-current.min.js
js-agent.newrelic.com/
59 KB
21 KB
Script
General
Full URL
https://js-agent.newrelic.com/nr-loader-spa-current.min.js
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?interactionId=yoSHYsdDdtgLdlR6c8nf5Os0-P55l_TpeNts6QMSPvXoGYF-H4L2fg%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=31425&nl_campaignid=1402&profileId=339331579&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=4&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&source=DGPTLessons
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2602:816:5001::39 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
5efe3ce0810792ef8434737ecc1b22518045e6088490faeb2350b1071a1d93d5
Security Headers
Name Value
Strict-Transport-Security max-age=300

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://dougallgpt.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

x-amz-version-id
U9B9u9EmWzttaLp8G6nl7.ExxzIIK7zO
content-encoding
br
via
1.1 varnish
date
Sun, 02 Jun 2024 12:21:37 GMT
strict-transport-security
max-age=300
x-amz-request-id
YSJ0GY6R8ZHWWSCC
x-amz-server-side-encryption
AES256
x-cache
HIT
cross-origin-resource-policy
cross-origin
content-length
21393
x-amz-id-2
Ye2c2J/fP4XR1fDFxOyGNgOa3JkkxZP6oPNS7oMwhH3wT08Pst49RgeoaAIvZMQqG844yiwt1lVKa3hs6ZKNpA==
x-served-by
cache-fra-eddf8230049-FRA
last-modified
Mon, 20 May 2024 17:45:24 GMT
server
AmazonS3
etag
"1a8a7b3115f7388935e47d9c3213b6c2"
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=7200, stale-while-revalidate=600, stale-if-error=600
accept-ranges
bytes
x-cache-hits
15
verify
phnx.dougallgpt.com/v2/auth/token/
0
0
Preflight
General
Full URL
https://phnx.dougallgpt.com/v2/auth/token/verify
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.19.240 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
*/*
Access-Control-Request-Headers
authorization,content-type
Access-Control-Request-Method
POST
Origin
https://dougallgpt.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

access-control-allow-headers
Content-Type,X-Amz-Date,Authorization,X-Api-Key,X-Amz-Security-Token,X-Amz-User-Agent,X-Amzn-Trace-Id
access-control-allow-methods
OPTIONS,POST
access-control-allow-origin
*
alt-svc
h3=":443"; ma=86400
cf-cache-status
DYNAMIC
cf-ray
88d767806b6c9b2d-FRA
content-length
0
content-type
application/json
date
Sun, 02 Jun 2024 12:21:38 GMT
server
cloudflare
strict-transport-security
max-age=31536000; includeSubDomains; preload
via
1.1 7f0813b44b225b7cfed233d5c2caab52.cloudfront.net (CloudFront), 1.1 78e03c1b28d33ab75a53563ffdf54ba6.cloudfront.net (CloudFront)
x-amz-apigw-id
YvSI3F6bjoEEqOA=
x-amz-cf-id
TkFTPulJS2XwcvyJkoYZbxpUAz3BH4LT5EA8YLkqAKE-vmDBJ-PjGg==
x-amz-cf-pop
AMS58-P6 AMS58-P4
x-amzn-requestid
84eb28d2-45de-4629-86c5-4644f71baf1a
x-cache
Miss from cloudfront
x-content-type-options
nosniff
piwik.js
a.dougallgpt.com/
64 KB
22 KB
Script
General
Full URL
https://a.dougallgpt.com/piwik.js
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?interactionId=yoSHYsdDdtgLdlR6c8nf5Os0-P55l_TpeNts6QMSPvXoGYF-H4L2fg%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=31425&nl_campaignid=1402&profileId=339331579&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=4&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&source=DGPTLessons
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:12f0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
d7fc375178c93a2fc15fd888e30170eedf4ef3d04497e7f951ab7bfe0c921693
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://dougallgpt.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 12:21:38 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-content-type-options
nosniff
cf-cache-status
HIT
last-modified
Wed, 01 Feb 2023 19:30:44 GMT
server
cloudflare
content-encoding
gzip
etag
W/"63dabde4-10132"
vary
Accept-Encoding
content-type
application/javascript
cache-control
public, max-age=14400
cf-ray
88d767807a062c5e-FRA
alt-svc
h3=":443"; ma=86400
expires
Sun, 02 Jun 2024 16:21:38 GMT
verify
phnx.dougallgpt.com/v2/auth/token/
2 KB
2 KB
XHR
General
Full URL
https://phnx.dougallgpt.com/v2/auth/token/verify
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?interactionId=yoSHYsdDdtgLdlR6c8nf5Os0-P55l_TpeNts6QMSPvXoGYF-H4L2fg%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=31425&nl_campaignid=1402&profileId=339331579&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=4&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&source=DGPTLessons
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.19.240 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
6a1afe20d864179a407958b08cbc3aad23e2d3a4bb42eb87f7d3efd473c0bf53
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
Authorization
Bearer eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
Content-Type
application/json
Accept
application/json, text/plain, */*
Referer
https://dougallgpt.com/
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 12:21:38 GMT
content-encoding
gzip
via
1.1 9c7ba0aaf8652834e3f6b51b901da726.cloudfront.net (CloudFront), 1.1 78e03c1b28d33ab75a53563ffdf54ba6.cloudfront.net (CloudFront)
cf-cache-status
DYNAMIC
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
AMS58-P6, AMS58-P4
x-amzn-requestid
c993daa3-e146-4600-972e-fe42825d4f28
x-cache
Miss from cloudfront
x-amz-apigw-id
YvSI4G5wDoEEEuA=
content-length
850
alt-svc
h3=":443"; ma=86400
server
cloudflare
x-amzn-trace-id
Root=1-665c63d2-7bf9b95f15bc84f6363b2ea6;Parent=60521b79c5f72ab4;Sampled=0;lineage=03d16b22:0|6f512099:0
content-type
application/json
access-control-allow-origin
*
access-control-allow-credentials
true
cf-ray
88d767811c459b2d-FRA
x-amz-cf-id
UrNxahQXoVgPyGSPg-ARyC56y5K3aX_jneJOAJd5KHiA5xLFK7_PQA==
favicon.ico
dougallgpt.com/
103 KB
13 KB
Other
General
Full URL
https://dougallgpt.com/favicon.ico
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.18.240 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
be30663f2e8e90a0f13fe1a1ab2a72e30d55fbcdc0f75da37f9d69d7a51fba47
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options DENY

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://dougallgpt.com/nl-external
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 12:21:38 GMT
x-amz-version-id
sKIoTnhiJuTXpdRy48R7eE9zxVHSeOCr
via
1.1 08f9b351f61685659ad70b790734f9b0.cloudfront.net (CloudFront)
cf-cache-status
REVALIDATED
content-encoding
gzip
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-request-id
PVXCGKZV752CT5TT
x-amz-cf-pop
VIE50-P2
x-amz-server-side-encryption
AES256
x-cache
Miss from cloudfront
alt-svc
h3=":443"; ma=86400
x-amz-id-2
ftDrRxoYiWdu2zBSQFljH5qy2+4Ghv6nVxM/Fxig0E+aujdtous821D4zpFF5EQF/zPLfmbrKuY=
last-modified
Wed, 15 May 2024 15:45:27 GMT
server
cloudflare
etag
W/"61956c7ede9f7faa6867c0cae21b649b"
x-frame-options
DENY
vary
Accept-Encoding
content-type
image/vnd.microsoft.icon
cache-control
public, max-age=14400
cf-ray
88d767803d7503a0-FRA
x-amz-cf-id
qYJ4qUId0LokG2q87ctWGoji3NxvAqGnkz4SfH5CWElm3rzn2Lczag==
expires
Sun, 02 Jun 2024 16:21:38 GMT
dougall-favicon.svg
c-phnx.dougallgpt.com/assets/sites/dougallgpt/
566 B
1 KB
Other
General
Full URL
https://c-phnx.dougallgpt.com/assets/sites/dougallgpt/dougall-favicon.svg
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.18.240 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
3d7e43ddf3870d3a17d97dd1956b94eced8d3301f9bfdef669b9f52a04d71a9e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://dougallgpt.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 12:21:38 GMT
content-encoding
7bit
via
1.1 d46464e02ca4f5540906664a2cfbcce2.cloudfront.net (CloudFront)
x-amz-version-id
qQo7V2uIW1sLIWK0VsHkulG55AoSTJQx
cf-cache-status
REVALIDATED
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
AMS1-P2
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
566
last-modified
Thu, 04 May 2023 16:11:30 GMT
server
cloudflare
etag
"6267ef2d20007330a9c16eee2e1ba6df"
vary
Origin, Accept-Encoding
content-type
image/svg+xml
cache-control
public, max-age=14400
accept-ranges
bytes
cf-ray
88d7678069356901-FRA
x-amz-cf-id
0W4bYwlh0ddMzSQQzQaU6R5Z1TdcAgUI-Vq1BINvdnB4JjlnbZT0iA==
expires
Sun, 02 Jun 2024 16:21:38 GMT
dougall-favicon.svg
c-phnx.dougallgpt.com/assets/sites/dougallgpt/
566 B
0
Other
General
Full URL
https://c-phnx.dougallgpt.com/assets/sites/dougallgpt/dougall-favicon.svg
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.18.240 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
3d7e43ddf3870d3a17d97dd1956b94eced8d3301f9bfdef669b9f52a04d71a9e
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://dougallgpt.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 12:21:38 GMT
content-encoding
7bit
via
1.1 d46464e02ca4f5540906664a2cfbcce2.cloudfront.net (CloudFront)
x-amz-version-id
qQo7V2uIW1sLIWK0VsHkulG55AoSTJQx
cf-cache-status
REVALIDATED
x-content-type-options
nosniff
x-amz-cf-pop
AMS1-P2
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
566
last-modified
Thu, 04 May 2023 16:11:30 GMT
server
cloudflare
etag
"6267ef2d20007330a9c16eee2e1ba6df"
vary
Origin, Accept-Encoding
content-type
image/svg+xml
cache-control
public, max-age=14400
accept-ranges
bytes
cf-ray
88d7678069356901-FRA
x-amz-cf-id
0W4bYwlh0ddMzSQQzQaU6R5Z1TdcAgUI-Vq1BINvdnB4JjlnbZT0iA==
expires
Sun, 02 Jun 2024 16:21:38 GMT
nr-spa-1.260.1.min.js
js-agent.newrelic.com/
106 KB
34 KB
Script
General
Full URL
https://js-agent.newrelic.com/nr-spa-1.260.1.min.js
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?interactionId=yoSHYsdDdtgLdlR6c8nf5Os0-P55l_TpeNts6QMSPvXoGYF-H4L2fg%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=31425&nl_campaignid=1402&profileId=339331579&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=4&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&source=DGPTLessons
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2602:816:5001::39 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
f941e01a27c4568da7a81f5cb516b5d2056b14b88cccf3c53f647bde767e0919
Security Headers
Name Value
Strict-Transport-Security max-age=300

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://dougallgpt.com/
Origin
https://dougallgpt.com
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

x-amz-version-id
Yrbdc1GL627m.B3Rf5_UelmBfBfYfLKU
content-encoding
br
via
1.1 varnish
date
Sun, 02 Jun 2024 12:21:37 GMT
strict-transport-security
max-age=300
x-amz-request-id
C18Q9GZGDB76CJP0
x-amz-server-side-encryption
AES256
x-cache
HIT
cross-origin-resource-policy
cross-origin
content-length
34121
x-amz-id-2
I4CtaVD3/eXa3oqlW9MTF7VBxUZO5h7vaoHIdfibg6XM7vGmbEkSqaX1jOHmNKquyhCQ3Dp/eO8=
x-served-by
cache-fra-etou8220033-FRA
last-modified
Mon, 20 May 2024 17:44:49 GMT
server
AmazonS3
etag
"1221654800ab387071aa9e0bf5b47dde"
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000, stale-while-revalidate=86400, stale-if-error=86400
accept-ranges
bytes
x-cache-hits
320724
NRJS-c1e44b406a79b06158d
bam.eu01.nr-data.net/1/
150 B
650 B
XHR
General
Full URL
https://bam.eu01.nr-data.net/1/NRJS-c1e44b406a79b06158d?a=538464710&sa=1&v=1.260.1&t=Unnamed%20Transaction&rst=1848&ck=0&s=075ffd1be4dd7d2d&ref=https://dougallgpt.com/nl-external&ptid=23066346c92b8456&af=err,xhr,stn,ins,spa&be=1243&fe=537&dc=536&fsh=1&perf=%7B%22timing%22:%7B%22of%22:1717330896165,%22n%22:0,%22f%22:985,%22dn%22:985,%22dne%22:985,%22c%22:985,%22s%22:985,%22ce%22:985,%22rq%22:986,%22rp%22:1244,%22rpe%22:1245,%22di%22:1666,%22ds%22:1778,%22de%22:1779,%22dc%22:1779,%22l%22:1779,%22le%22:1780%7D,%22navigation%22:%7B%7D%7D
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?interactionId=yoSHYsdDdtgLdlR6c8nf5Os0-P55l_TpeNts6QMSPvXoGYF-H4L2fg%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=31425&nl_campaignid=1402&profileId=339331579&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=4&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&source=DGPTLessons
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
185.221.87.23 , Ireland, ASN54113 (FASTLY, US),
Reverse DNS
Software
istio-envoy /
Resource Hash
8ba6f3aca47aea9755af014479e8cb1e98236507fa4a075bb9c208c1be7f06e5

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://dougallgpt.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Sun, 02 Jun 2024 12:21:38 GMT
server
istio-envoy
access-control-allow-methods
GET, POST, PUT, HEAD, OPTIONS
content-type
text/plain
access-control-allow-origin
https://dougallgpt.com
access-control-expose-headers
Date
access-control-allow-credentials
true
x-envoy-upstream-service-time
4
cross-origin-resource-policy
cross-origin
Connection
keep-alive
timing-allow-origin
https://dougallgpt.com
Content-Length
150
x-served-by
cache-fra-etou8220097-FRA
blobs
bam.eu01.nr-data.net/browser/
24 B
341 B
XHR
General
Full URL
https://bam.eu01.nr-data.net/browser/blobs?browser_monitoring_key=NRJS-c1e44b406a79b06158d&type=BrowserSessionChunk&app_id=538464710&protocol_version=0&timestamp=1717330896121&attributes=entityGuid%3DMzE1MTQzMHxCUk9XU0VSfEFQUExJQ0FUSU9OfDUzODQ2NDcxMA%26harvestId%3D075ffd1be4dd7d2d_23066346c92b8456_1%26trace.firstTimestamp%3D1717330896121%26trace.lastTimestamp%3D1717330897901%26trace.nodes%3D26%26trace.originTimestamp%3D1717330896121%26agentVersion%3D1.260.1%26firstSessionHarvest%3Dtrue%26ptid%3D23066346c92b8456%26session%3D075ffd1be4dd7d2d
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?interactionId=yoSHYsdDdtgLdlR6c8nf5Os0-P55l_TpeNts6QMSPvXoGYF-H4L2fg%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=31425&nl_campaignid=1402&profileId=339331579&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=4&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&source=DGPTLessons
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
185.221.87.23 , Ireland, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
0c9cf152a0ad00d4f102c93c613c104914be5517ac8f8e0831727f8bfbe8b300

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://dougallgpt.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Sun, 02 Jun 2024 12:21:38 GMT
access-control-allow-methods
GET, POST, PUT, HEAD, OPTIONS
content-type
image/gif
access-control-allow-origin
https://dougallgpt.com
access-control-allow-credentials
true
Connection
keep-alive
Content-Length
24
x-served-by
cache-fra-etou8220097-FRA
NRJS-c1e44b406a79b06158d
bam.eu01.nr-data.net/events/1/
24 B
341 B
XHR
General
Full URL
https://bam.eu01.nr-data.net/events/1/NRJS-c1e44b406a79b06158d?a=538464710&sa=1&v=1.260.1&t=Unnamed%20Transaction&rst=1935&ck=0&s=075ffd1be4dd7d2d&ref=https://dougallgpt.com/nl-external&ptid=23066346c92b8456
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?interactionId=yoSHYsdDdtgLdlR6c8nf5Os0-P55l_TpeNts6QMSPvXoGYF-H4L2fg%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=31425&nl_campaignid=1402&profileId=339331579&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=4&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&source=DGPTLessons
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
185.221.87.23 , Ireland, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
0c9cf152a0ad00d4f102c93c613c104914be5517ac8f8e0831727f8bfbe8b300

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://dougallgpt.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Sun, 02 Jun 2024 12:21:38 GMT
access-control-allow-methods
GET, POST, PUT, HEAD, OPTIONS
content-type
image/gif
access-control-allow-origin
https://dougallgpt.com
access-control-allow-credentials
true
Connection
keep-alive
Content-Length
24
x-served-by
cache-fra-etou8220097-FRA
locale-dgpt.json
c-phnx.dougallgpt.com/assets/misc/locale/
655 KB
656 KB
XHR
General
Full URL
https://c-phnx.dougallgpt.com/assets/misc/locale/locale-dgpt.json
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?interactionId=yoSHYsdDdtgLdlR6c8nf5Os0-P55l_TpeNts6QMSPvXoGYF-H4L2fg%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=31425&nl_campaignid=1402&profileId=339331579&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=4&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&source=DGPTLessons
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.18.240 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Accept
application/json, text/plain, */*
Referer
https://dougallgpt.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 12:21:38 GMT
content-encoding
7bit
via
1.1 ec1ac21acdbd36c971eca9d6b61d0744.cloudfront.net (CloudFront)
x-amz-version-id
wnPtKIsvGodtWfoSrATLbWghLhlKwdMz
cf-cache-status
DYNAMIC
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA60-P1
age
30387
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
x-amz-storage-class
INTELLIGENT_TIERING
alt-svc
h3=":443"; ma=86400
content-length
670518
last-modified
Wed, 15 May 2024 15:17:29 GMT
server
cloudflare
etag
"423eb6a21230c23b6c28be258abcd605"
access-control-max-age
3000
access-control-allow-methods
GET, HEAD
content-type
application/json
access-control-allow-origin
https://dougallgpt.com
access-control-expose-headers
x-amz-server-side-encryption, x-amz-request-id, x-amz-id-2
vary
Accept-Encoding,Origin,Access-Control-Request-Headers,Access-Control-Request-Method
access-control-allow-credentials
true
accept-ranges
bytes
cf-ray
88d76785e8b02c39-FRA
x-amz-cf-id
TZq-85Ra96cst-1K5PZibkdvg7pgBFnSDMJzkmi3QKpE3oda9KfVsA==
client.js
c-neml.dougallgpt.com/device/
43 KB
17 KB
Script
General
Full URL
https://c-neml.dougallgpt.com/device/client.js
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?interactionId=yoSHYsdDdtgLdlR6c8nf5Os0-P55l_TpeNts6QMSPvXoGYF-H4L2fg%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=31425&nl_campaignid=1402&profileId=339331579&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=4&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&source=DGPTLessons
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.18.240 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://dougallgpt.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 12:21:38 GMT
via
1.1 62e2e45895008240d70f26081269c850.cloudfront.net (CloudFront)
x-content-type-options
nosniff
cf-cache-status
HIT
content-encoding
gzip
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA60-P5
age
18
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
last-modified
Tue, 16 Apr 2024 14:28:29 GMT
server
cloudflare
etag
W/"743b629c2fd75a3bf9d68ff918e30d94"
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=14400
cf-ray
88d767860bc3698b-FRA
x-amz-cf-id
PrA_eMn13mLRvjBqfN_WssuCWE7xs9oPG3XVibyBydVaUYVAqcKw0Q==
expires
Sun, 02 Jun 2024 16:21:38 GMT
Primary Request eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer
dougallmd.com/article/
Redirect Chain
  • https://dougallmd.com/omni/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwia...
  • https://dougallmd.com/omni/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3...
  • https://api.phnxml.io/v2/auth/token/omni?siteId=530&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsI...
  • https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMep...
31 KB
11 KB
Document
General
Full URL
https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/static/js/main.c2d4dc5b.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.10.172 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
ab24e0732a17ccf52ea81bf7685fcb430ef7bcb6eda27254265e3f2b0cf0f093
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options DENY

Request headers

Accept-Language
de-DE,de;q=0.9;q=0.9
Referer
https://dougallgpt.com/nl-external
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

alt-svc
h3=":443"; ma=86400
cf-cache-status
DYNAMIC
cf-ray
88d7678b5a1b35f3-FRA
content-encoding
gzip
content-type
text/html
date
Sun, 02 Jun 2024 12:21:40 GMT
last-modified
Thu, 30 May 2024 19:34:49 GMT
server
cloudflare
strict-transport-security
max-age=31536000; includeSubDomains; preload
vary
Accept-Encoding
via
1.1 cce339e34372cea758a4181fcf4e7c14.cloudfront.net (CloudFront)
x-amz-cf-id
iguHY6b6mFB9WgvTUjgP0j42uweKi62uTi-cEHYSBsi6d_j-QC2_aQ==
x-amz-cf-pop
FRA60-P7
x-amz-id-2
4s6ESvwn8lqLtBNPabJDf+eNY6l+5q1dKLz6r3UlQOWAPNCCVQEPMaY0gwWvaCvZO46kI8Klw6o=
x-amz-request-id
R1B66ZP3RJFW3261
x-amz-server-side-encryption
AES256
x-amz-version-id
7er1wVpZufaNo_mK_rt_SKc98Z5GnoUR
x-cache
Miss from cloudfront
x-content-type-options
nosniff
x-frame-options
DENY

Redirect headers

content-length
0
content-type
application/json
date
Sun, 02 Jun 2024 12:21:39 GMT
location
https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
via
1.1 56a77d6c9e6b49fa4179a99507a9582e.cloudfront.net (CloudFront), 1.1 1a3d61cabf9778724765b3e70befe816.cloudfront.net (CloudFront)
x-amz-apigw-id
YvSJFEzqDoEEAOg=
x-amz-cf-id
D8zFFpr8l4HMEfFzNDMyeww2rMX4cZS8nb5k-Ob2RrwA2fIbTHKEJg==
x-amz-cf-pop
FRA60-P6 FRA56-C2
x-amzn-requestid
a99835a4-eab1-406b-9b82-3d02a0882254
x-amzn-trace-id
Root=1-665c63d3-29a7ce446bc6061252f53cab;Parent=3953782d3c97a07b;Sampled=0;lineage=0551940c:0
x-cache
Miss from cloudfront
piwik.php
a.dougallgpt.com/
0
781 B
Ping
General
Full URL
https://a.dougallgpt.com/piwik.php
Requested by
Host: a.dougallgpt.com
URL: https://a.dougallgpt.com/piwik.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:12f0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare / PHP/8.1.28
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://dougallgpt.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=utf-8

Response headers

date
Sun, 02 Jun 2024 12:21:39 GMT
content-encoding
none
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
cf-cache-status
DYNAMIC
server
cloudflare
x-powered-by
PHP/8.1.28
content-security-policy-report-only
script-src 'none'; connect-src 'none'; report-uri https://csp-reporting.cloudflare.com/cdn-cgi/script_monitor/report?m=zRjX5rRVkDPWZW01ChaNzK7kYiumFdjW4LYWbGe2MV4-1717330899-1.0.1.1-0IaaV7VmSn2F3Dq8qtA3PIOgHy8TDnjAkjlKyCwCb3E9sY5MpkWTTqxhw2hxXikt5TxESEGXAHPHPqGkE2H5rikhRyYEkgqGCqx2WQ0mc88h1nO9sVHEkPymxV0RjAHzoHtKE0AIe1qWVXbrHXvCO.rTYCgqU2omqxacnBTUby0; report-to cf-csp-endpoint
report-to
{"endpoints":[{"url":"https:\/\/csp-reporting.cloudflare.com\/cdn-cgi\/script_monitor\/report?m=zRjX5rRVkDPWZW01ChaNzK7kYiumFdjW4LYWbGe2MV4-1717330899-1.0.1.1-0IaaV7VmSn2F3Dq8qtA3PIOgHy8TDnjAkjlKyCwCb3E9sY5MpkWTTqxhw2hxXikt5TxESEGXAHPHPqGkE2H5rikhRyYEkgqGCqx2WQ0mc88h1nO9sVHEkPymxV0RjAHzoHtKE0AIe1qWVXbrHXvCO.rTYCgqU2omqxacnBTUby0"}],"group":"cf-csp-endpoint","max_age":86400}
access-control-allow-origin
https://dougallgpt.com
access-control-allow-credentials
true
cf-ray
88d76785ea712c5e-FRA
alt-svc
h3=":443"; ma=86400
RelevantID4.js
dougallgpt.com/prx/rvid/
191 KB
35 KB
XHR
General
Full URL
https://dougallgpt.com/prx/rvid/RelevantID4.js
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?interactionId=yoSHYsdDdtgLdlR6c8nf5Os0-P55l_TpeNts6QMSPvXoGYF-H4L2fg%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=31425&nl_campaignid=1402&profileId=339331579&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=4&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&source=DGPTLessons
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.18.240 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options DENY

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
tracestate
2926632@nr=0-1-3151430-538464710-8d43dab751a62bda----1717330898971, 2926632@nr=0-1-3151430-538464710-000f51df76c31ca4----1717330898971
traceparent
00-a11ab76036eaadddc78afb372ebfed05-8d43dab751a62bda-01, 00-609425f23909b83f5479dfbc250a1a96-000f51df76c31ca4-01
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
newrelic
eyJ2IjpbMCwxXSwiZCI6eyJ0eSI6IkJyb3dzZXIiLCJhYyI6IjMxNTE0MzAiLCJhcCI6IjUzODQ2NDcxMCIsImlkIjoiOGQ0M2RhYjc1MWE2MmJkYSIsInRyIjoiYTExYWI3NjAzNmVhYWRkZGM3OGFmYjM3MmViZmVkMDUiLCJ0aSI6MTcxNzMzMDg5ODk3MSwidGsiOiIyOTI2NjMyIn19, eyJ2IjpbMCwxXSwiZCI6eyJ0eSI6IkJyb3dzZXIiLCJhYyI6IjMxNTE0MzAiLCJhcCI6IjUzODQ2NDcxMCIsImlkIjoiMDAwZjUxZGY3NmMzMWNhNCIsInRyIjoiNjA5NDI1ZjIzOTA5YjgzZjU0NzlkZmJjMjUwYTFhOTYiLCJ0aSI6MTcxNzMzMDg5ODk3MSwidGsiOiIyOTI2NjMyIn19
Accept
application/json, text/plain, */*
Referer
https://dougallgpt.com/nl-external
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 12:21:39 GMT
via
1.1 1f49a084ca923f375f74b42fa36ef428.cloudfront.net (CloudFront), 1.1 b43c04a791e8dcb8ddb6bb0847fcf95a.cloudfront.net (CloudFront)
content-encoding
gzip
cf-cache-status
REVALIDATED
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA50-C1, FRA60-P3
x-amz-server-side-encryption
AES256
x-cache
Miss from cloudfront
alt-svc
h3=":443"; ma=86400
last-modified
Wed, 03 Apr 2024 13:27:29 GMT
server
cloudflare
etag
W/"ecfcfbb1297ac0d98b5afa9c144995a1"
vary
Accept-Encoding
x-frame-options
DENY
content-type
application/javascript
cache-control
public, max-age=14400
cf-ray
88d76786994003a0-FRA
x-amz-cf-id
cNbyfKgcmyWXybhwfi6K0cA4NU6EycRje7MMskzzKyI2eagtWhIyFw==
expires
Sun, 02 Jun 2024 16:21:39 GMT
UcC73FwrK3iLTeHuS_fvQtMwCp50KnMa1ZL7.woff2
fonts.gstatic.com/s/inter/v13/
46 KB
46 KB
Font
General
Full URL
https://fonts.gstatic.com/s/inter/v13/UcC73FwrK3iLTeHuS_fvQtMwCp50KnMa1ZL7.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Inter:400,700
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:827::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://fonts.googleapis.com/
Origin
https://dougallgpt.com
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Sat, 01 Jun 2024 01:47:47 GMT
x-content-type-options
nosniff
age
124432
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
46704
x-xss-protection
0
last-modified
Wed, 13 Sep 2023 23:49:07 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 01 Jun 2025 01:47:47 GMT
dedupe
rvid.imperium.com/
0
0
Preflight
General
Full URL
https://rvid.imperium.com/dedupe
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.205.46.52 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-205-46-52.compute-1.amazonaws.com
Software
Kestrel /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type,x-clientid
Access-Control-Request-Method
POST
Origin
https://dougallgpt.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

access-control-allow-headers
content-type,x-clientid
access-control-allow-methods
POST
access-control-allow-origin
*
date
Sun, 02 Jun 2024 12:21:39 GMT
server
Kestrel
dedupe
rvid.imperium.com/
2 KB
2 KB
XHR
General
Full URL
https://rvid.imperium.com/dedupe
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?interactionId=yoSHYsdDdtgLdlR6c8nf5Os0-P55l_TpeNts6QMSPvXoGYF-H4L2fg%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=31425&nl_campaignid=1402&profileId=339331579&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=4&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&source=DGPTLessons
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.205.46.52 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-205-46-52.compute-1.amazonaws.com
Software
Kestrel /
Resource Hash

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
X-ClientID
BC170856-91EA-11ED-A210-1264B5C78F33
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
Content-Type
application/json
Referer
https://dougallgpt.com/
sec-ch-ua-platform
"Win32"

Response headers

access-control-allow-origin
*
date
Sun, 02 Jun 2024 12:21:39 GMT
server
Kestrel
content-length
2084
content-type
application/json; charset=utf-8
rvid
api.neml.io/device/
51 B
830 B
XHR
General
Full URL
https://api.neml.io/device/rvid
Requested by
Host: dougallgpt.com
URL: https://dougallgpt.com/nl-external?interactionId=yoSHYsdDdtgLdlR6c8nf5Os0-P55l_TpeNts6QMSPvXoGYF-H4L2fg%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80&nl_site=dougallgpt_smartvite&nl_ref=newsletter&pk_campaign=newsletter&nl_eventid=31425&nl_campaignid=1402&profileId=339331579&idhSiteId=1020&idhBrandId=154&article_id=5676151&fb_id=5676151&pnumber=&pw_siteID=146&articleTitle=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&destUrl=https%3A%2F%2Fdougallmd.com%2Fomni%2Farticle%2Feftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer%3Fdp%3DeyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUyOSwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MjktYzI3NDAwNmYtNWRmMy00YjY5LWI3MGYtYzAyMWEwOWFjYmIwIiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbGdwdC5jb20iLCJpc3N1ZXIiOiJwaG9lbml4IiwiaWF0IjoxNzE3MDkyMjQ2LCJleHAiOjE3MTk2ODQyNDZ9.6eOWg28LUrE2HYSN6DR1a-woVizoqSAMp9j7E3esw80%26article_id%3D5676151%26article_title%3DEftilagimod%2520Improves%2520Efficacy%2520of%2520Pembrolizumab%2520in%2520First-Line%2520Treatment%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26source%3Ddougallgpt&pos=4&external=true&human_url=eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&source=DGPTLessons
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
108.138.36.76 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-108-138-36-76.muc50.r.cloudfront.net
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
Content-Type
text/plain
Accept
application/json, text/plain, */*
Referer
https://dougallgpt.com/
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 12:21:40 GMT
content-encoding
gzip
via
1.1 7b7e33ce27dedf9c28b39ecc0309b556.cloudfront.net (CloudFront), 1.1 9f8416bf8a85d328bf3649469ef2a474.cloudfront.net (CloudFront)
x-content-type-options
nosniff
strict-transport-security
max-age=31536000
x-amz-cf-pop
MUC50-P5, MUC50-P2
x-amzn-requestid
71e35a69-731c-4e99-995f-d735e11cfe86
x-cache
Miss from cloudfront
x-amz-apigw-id
YvSJJEF0joEEnwg=
content-length
71
x-xss-protection
1; mode=block
referrer-policy
strict-origin-when-cross-origin
x-amzn-trace-id
Root=1-665c63d3-561732ee42d3b9183ca3274a;Parent=77ae4201c8690872;Sampled=0;lineage=b9d4f140:0
vary
Origin
access-control-allow-methods
POST, OPTIONS
content-type
application/json
access-control-allow-origin
https://dougallgpt.com
x-frame-options
SAMEORIGIN
access-control-allow-credentials
true
access-control-allow-headers
*, Content-Type, Authorization
x-amz-cf-id
2_w4VshmJJZki-oiy5aVl9aRObAoaRNZdeauIUTK-qDqW51uxq-c_g==
css
fonts.googleapis.com/
4 KB
731 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Inter:400,700
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
5848917b31a4f0f69ab224f717c6290d8771b9a2a374d1c024b6b8f218b3ad99
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://dougallmd.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

strict-transport-security
max-age=31536000
date
Sun, 02 Jun 2024 12:21:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
0
last-modified
Sun, 02 Jun 2024 12:21:14 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Sun, 02 Jun 2024 12:21:40 GMT
css
fonts.googleapis.com/
2 KB
964 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Raleway
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
cdbcbb6ab7680b6f7ee6f09ff2a54b0e8e3eb6e758efb1c0a7fe5e71fb0da118
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://dougallmd.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

strict-transport-security
max-age=31536000
date
Sun, 02 Jun 2024 12:21:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
0
last-modified
Sun, 02 Jun 2024 11:25:04 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Sun, 02 Jun 2024 12:21:40 GMT
main.219d6e7a.js
dougallmd.com/static/js/
3 MB
692 KB
Script
General
Full URL
https://dougallmd.com/static/js/main.219d6e7a.js
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.10.172 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
c134d0629fa82e086972ef8ce1ccad1b45d28064cf56d261862a99b9c021f85d
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options DENY

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 12:21:40 GMT
x-amz-version-id
tVYyTqSkn5aTTduQdsju_MAi56Te.xiy
content-encoding
gzip
cf-cache-status
HIT
via
1.1 6f4aa26c09fb9bb4d152519f44256a4c.cloudfront.net (CloudFront)
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-request-id
BZNHZR6V803C1Q57
x-amz-cf-pop
FRA60-P7
x-amz-server-side-encryption
AES256
x-cache
Miss from cloudfront
x-amz-storage-class
INTELLIGENT_TIERING
alt-svc
h3=":443"; ma=86400
x-amz-id-2
zKRl0hyflG15TdGDKW1xDDSKPtnaSss6qC+hMKAQ3TWgXNpLMpAW32CGtbjGP10L8DjB1Q1Kmjg=
last-modified
Thu, 30 May 2024 19:34:49 GMT
server
cloudflare
etag
W/"76f630fd0c4d12be49b72fda5bc012e4"
vary
Accept-Encoding
x-frame-options
DENY
content-type
text/javascript
cache-control
public, max-age=14400
cf-ray
88d7678e3dee35f3-FRA
x-amz-cf-id
uhcCsD6cOoHv29L_Hq0pO16ZXeiXDWLOTs4xMGgn4VRJWy8360cpVg==
expires
Sun, 02 Jun 2024 16:21:40 GMT
main.30ae19ef.css
dougallmd.com/static/css/
68 KB
12 KB
Stylesheet
General
Full URL
https://dougallmd.com/static/css/main.30ae19ef.css
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.10.172 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
fa1efa2060178b956e3c8c8c45ee50180713781b320c149dd86ead5ff06d3163
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options DENY

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 12:21:40 GMT
x-amz-version-id
wVL3JLph_LNoYxScw7y4gT71muh0uYa4
content-encoding
gzip
cf-cache-status
REVALIDATED
via
1.1 69114e4ea0aa4e532a5be63a75c51e2c.cloudfront.net (CloudFront)
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-request-id
VDXDR7H19X9XGD31
x-amz-cf-pop
FRA60-P7
x-amz-server-side-encryption
AES256
x-cache
Miss from cloudfront
alt-svc
h3=":443"; ma=86400
x-amz-id-2
nCo9RKzr/zklWctEKkt0tZ2Z3VhNMdyvA2t9ZeP+WQFwhMzRQpkmshhrLm7cZ0KR966u4z3U6jg=
last-modified
Wed, 15 May 2024 15:56:19 GMT
server
cloudflare
etag
W/"eff57de8fe48b288d86e7aba1cbd3c8f"
vary
Accept-Encoding
x-frame-options
DENY
content-type
text/css
cache-control
public, max-age=14400
cf-ray
88d7678dfd9c35f3-FRA
x-amz-cf-id
m9KsBZDqoSVUhbNuub4bRnWWBLyH9ZfhJ4J5BVQ5r4Dfq6Ld8pLTwg==
expires
Sun, 02 Jun 2024 16:21:40 GMT
sasia.min.js
content.aimatch.com/js/sasia/v1/
6 KB
2 KB
Script
General
Full URL
https://content.aimatch.com/js/sasia/v1/sasia.min.js
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2.17.147.219 Prague, Czech Republic, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
a2-17-147-219.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
080b836d73ad378365492df072f69365eb76bca3ad7fe715d854b5cf012a493f

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://dougallmd.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

x-amz-version-id
null
content-encoding
gzip
date
Sun, 02 Jun 2024 12:21:40 GMT
last-modified
Tue, 16 Feb 2016 15:21:55 GMT
server
AmazonS3
x-amz-request-id
FG19XY1728KCCSQ0
etag
"c1a192142497cfc2d2def7217929e22b"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
max-age=3600
accept-ranges
bytes
content-length
2231
x-amz-id-2
DpxXrcqgZocFmMmQl1eJZTAz1r0a3fslvPeH8LX6ip+5fHjQDH7B0/7WQot9AUwx5TaAqIgOfok=
expires
Sun, 02 Jun 2024 13:21:40 GMT
css2
fonts.googleapis.com/
5 KB
740 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css2?family=EB+Garamond:wght@400;600&display=swap
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/static/css/main.30ae19ef.css
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
14d0333bd3bc84f7662a5956639e474a4d5db164fb2e43c8aa4097fca9eeed0c
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://dougallmd.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

strict-transport-security
max-age=31536000
date
Sun, 02 Jun 2024 12:21:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
0
last-modified
Sun, 02 Jun 2024 12:21:40 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Sun, 02 Jun 2024 12:21:40 GMT
nr-loader-spa-current.min.js
js-agent.newrelic.com/
59 KB
21 KB
Script
General
Full URL
https://js-agent.newrelic.com/nr-loader-spa-current.min.js
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2602:816:5001::39 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
5efe3ce0810792ef8434737ecc1b22518045e6088490faeb2350b1071a1d93d5
Security Headers
Name Value
Strict-Transport-Security max-age=300

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://dougallmd.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

x-amz-version-id
U9B9u9EmWzttaLp8G6nl7.ExxzIIK7zO
content-encoding
br
via
1.1 varnish
date
Sun, 02 Jun 2024 12:21:40 GMT
strict-transport-security
max-age=300
x-amz-request-id
YSJ0GY6R8ZHWWSCC
x-amz-server-side-encryption
AES256
x-cache
HIT
cross-origin-resource-policy
cross-origin
content-length
21393
x-amz-id-2
Ye2c2J/fP4XR1fDFxOyGNgOa3JkkxZP6oPNS7oMwhH3wT08Pst49RgeoaAIvZMQqG844yiwt1lVKa3hs6ZKNpA==
x-served-by
cache-fra-eddf8230118-FRA
last-modified
Mon, 20 May 2024 17:45:24 GMT
server
AmazonS3
etag
"1a8a7b3115f7388935e47d9c3213b6c2"
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=7200, stale-while-revalidate=600, stale-if-error=600
accept-ranges
bytes
x-cache-hits
19
verify
phnx.dougallmd.com/v2/auth/token/
0
0
Preflight
General
Full URL
https://phnx.dougallmd.com/v2/auth/token/verify
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:bac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
*/*
Access-Control-Request-Headers
authorization,content-type
Access-Control-Request-Method
POST
Origin
https://dougallmd.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

access-control-allow-headers
Content-Type,X-Amz-Date,Authorization,X-Api-Key,X-Amz-Security-Token,X-Amz-User-Agent,X-Amzn-Trace-Id
access-control-allow-methods
OPTIONS,POST
access-control-allow-origin
*
alt-svc
h3=":443"; ma=86400
cf-cache-status
DYNAMIC
cf-ray
88d7679089d05c44-FRA
content-length
0
content-type
application/json
date
Sun, 02 Jun 2024 12:21:40 GMT
server
cloudflare
strict-transport-security
max-age=31536000; includeSubDomains; preload
via
1.1 debf5a1694fcb96cc13d895660321eda.cloudfront.net (CloudFront), 1.1 2e4a0520ad8fe16707823b20e9441e08.cloudfront.net (CloudFront)
x-amz-apigw-id
YvSJRH5rDoEEuGw=
x-amz-cf-id
nIQSog5xO3BB_ynN5wD5Xu_IWTxDdyQ-7hAAct-f73s8mpTUs4HYyg==
x-amz-cf-pop
FRA60-P6 FRA56-C2
x-amzn-requestid
36cebe5a-e6a2-49dd-aebd-9196da8d1240
x-cache
Miss from cloudfront
x-content-type-options
nosniff
piwik.js
a.dougallmd.com/
64 KB
21 KB
Script
General
Full URL
https://a.dougallmd.com/piwik.js
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.10.172 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
d7fc375178c93a2fc15fd888e30170eedf4ef3d04497e7f951ab7bfe0c921693
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://dougallmd.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 12:21:40 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-content-type-options
nosniff
cf-cache-status
HIT
last-modified
Wed, 01 Feb 2023 19:30:44 GMT
server
cloudflare
content-encoding
gzip
etag
W/"63dabde4-10132"
vary
Accept-Encoding
content-type
application/javascript
cache-control
public, max-age=14400
cf-ray
88d76790596e35f3-FRA
alt-svc
h3=":443"; ma=86400
expires
Sun, 02 Jun 2024 16:21:40 GMT
verify
phnx.dougallmd.com/v2/auth/token/
2 KB
2 KB
XHR
General
Full URL
https://phnx.dougallmd.com/v2/auth/token/verify
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:bac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
01ea5160b4f1d1476d50cd7c9a920141e65eff8487e8dedaaeefe352974fbed2
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
Authorization
Bearer eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
Content-Type
application/json
Accept
application/json, text/plain, */*
Referer
https://dougallmd.com/
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 12:21:41 GMT
content-encoding
gzip
via
1.1 cbd5498107be7e5bcccda272c5fdbef4.cloudfront.net (CloudFront), 1.1 2e4a0520ad8fe16707823b20e9441e08.cloudfront.net (CloudFront)
cf-cache-status
DYNAMIC
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA60-P6, FRA56-C2
x-amzn-requestid
b3ff4946-ff3c-42c7-9cc5-d9faf2fad843
x-cache
Miss from cloudfront
x-amz-apigw-id
YvSJSE23joEEAOg=
content-length
948
alt-svc
h3=":443"; ma=86400
server
cloudflare
x-amzn-trace-id
Root=1-665c63d4-628728247fcfef5d5833939e;Parent=330f723be9694d95;Sampled=0;lineage=03d16b22:0|6f512099:0
content-type
application/json
access-control-allow-origin
*
access-control-allow-credentials
true
cf-ray
88d767916a9a5c44-FRA
x-amz-cf-id
wstYiYlGdoviCGBh-ibuAWU7bt2rkaxiwwawyxqm9yuskh__ztFHmg==
dougall-favicon.svg
c-phnx.dougallmd.com/assets/sites/dougallgpt/
566 B
1 KB
Other
General
Full URL
https://c-phnx.dougallmd.com/assets/sites/dougallgpt/dougall-favicon.svg
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.10.172 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
3d7e43ddf3870d3a17d97dd1956b94eced8d3301f9bfdef669b9f52a04d71a9e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://dougallmd.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 12:21:40 GMT
content-encoding
7bit
via
1.1 127aaaaca740f298a4c887357ec047b4.cloudfront.net (CloudFront)
x-amz-version-id
qQo7V2uIW1sLIWK0VsHkulG55AoSTJQx
cf-cache-status
REVALIDATED
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
CDG52-P2
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
566
last-modified
Thu, 04 May 2023 16:11:30 GMT
server
cloudflare
etag
"6267ef2d20007330a9c16eee2e1ba6df"
vary
Accept-Encoding, Origin
content-type
image/svg+xml
cache-control
public, max-age=14400
accept-ranges
bytes
cf-ray
88d7679099b035f3-FRA
x-amz-cf-id
R8L6Iv3spUKOyDnLXgPbCBpqf6MJQPVGVq4bahQUYDxkES18--Uq2A==
expires
Sun, 02 Jun 2024 16:21:40 GMT
nr-spa-1.260.1.min.js
js-agent.newrelic.com/
106 KB
34 KB
Script
General
Full URL
https://js-agent.newrelic.com/nr-spa-1.260.1.min.js
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2602:816:5001::39 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
f941e01a27c4568da7a81f5cb516b5d2056b14b88cccf3c53f647bde767e0919
Security Headers
Name Value
Strict-Transport-Security max-age=300

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://dougallmd.com/
Origin
https://dougallmd.com
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

x-amz-version-id
Yrbdc1GL627m.B3Rf5_UelmBfBfYfLKU
content-encoding
br
via
1.1 varnish
date
Sun, 02 Jun 2024 12:21:40 GMT
strict-transport-security
max-age=300
x-amz-request-id
C18Q9GZGDB76CJP0
x-amz-server-side-encryption
AES256
x-cache
HIT
cross-origin-resource-policy
cross-origin
content-length
34121
x-amz-id-2
I4CtaVD3/eXa3oqlW9MTF7VBxUZO5h7vaoHIdfibg6XM7vGmbEkSqaX1jOHmNKquyhCQ3Dp/eO8=
x-served-by
cache-fra-etou8220056-FRA
last-modified
Mon, 20 May 2024 17:44:49 GMT
server
AmazonS3
etag
"1221654800ab387071aa9e0bf5b47dde"
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000, stale-while-revalidate=86400, stale-if-error=86400
accept-ranges
bytes
x-cache-hits
175757
NRJS-c1e44b406a79b06158d
bam.eu01.nr-data.net/1/
150 B
648 B
XHR
General
Full URL
https://bam.eu01.nr-data.net/1/NRJS-c1e44b406a79b06158d?a=538464022&sa=1&v=1.260.1&t=Unnamed%20Transaction&rst=1721&ck=0&s=e59d79c91b1e4d8a&ref=https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&ptid=f746a59ef1f55c4b&af=err,xhr,stn,ins,spa&be=1285&fe=373&dc=372&fsh=1&perf=%7B%22timing%22:%7B%22of%22:1717330898861,%22n%22:0,%22f%22:868,%22dn%22:868,%22dne%22:868,%22c%22:868,%22s%22:868,%22ce%22:868,%22rq%22:869,%22rp%22:1285,%22rpe%22:1286,%22di%22:1548,%22ds%22:1657,%22de%22:1657,%22dc%22:1657,%22l%22:1658,%22le%22:1658%7D,%22navigation%22:%7B%7D%7D
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
185.221.87.23 , Ireland, ASN54113 (FASTLY, US),
Reverse DNS
Software
istio-envoy /
Resource Hash
fa49a45d600f0c9cf5e6416b76cc703ccaabf1b4b934efecb7a4d44a84ebe386

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://dougallmd.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Sun, 02 Jun 2024 12:21:40 GMT
server
istio-envoy
access-control-allow-methods
GET, POST, PUT, HEAD, OPTIONS
content-type
text/plain
access-control-allow-origin
https://dougallmd.com
access-control-expose-headers
Date
access-control-allow-credentials
true
x-envoy-upstream-service-time
3
cross-origin-resource-policy
cross-origin
Connection
keep-alive
timing-allow-origin
https://dougallmd.com
Content-Length
150
x-served-by
cache-fra-etou8220104-FRA
blobs
bam.eu01.nr-data.net/browser/
24 B
340 B
XHR
General
Full URL
https://bam.eu01.nr-data.net/browser/blobs?browser_monitoring_key=NRJS-c1e44b406a79b06158d&type=BrowserSessionChunk&app_id=538464022&protocol_version=0&timestamp=1717330898262&attributes=entityGuid%3DMzE1MTQzMHxCUk9XU0VSfEFQUExJQ0FUSU9OfDUzODQ2NDAyMg%26harvestId%3De59d79c91b1e4d8a_f746a59ef1f55c4b_1%26trace.firstTimestamp%3D1717330898262%26trace.lastTimestamp%3D1717330899920%26trace.nodes%3D26%26trace.originTimestamp%3D1717330898262%26agentVersion%3D1.260.1%26firstSessionHarvest%3Dtrue%26ptid%3Df746a59ef1f55c4b%26session%3De59d79c91b1e4d8a
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
185.221.87.23 , Ireland, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
0c9cf152a0ad00d4f102c93c613c104914be5517ac8f8e0831727f8bfbe8b300

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://dougallmd.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Sun, 02 Jun 2024 12:21:40 GMT
access-control-allow-methods
GET, POST, PUT, HEAD, OPTIONS
content-type
image/gif
access-control-allow-origin
https://dougallmd.com
access-control-allow-credentials
true
Connection
keep-alive
Content-Length
24
x-served-by
cache-fra-etou8220104-FRA
NRJS-c1e44b406a79b06158d
bam.eu01.nr-data.net/events/1/
24 B
340 B
XHR
General
Full URL
https://bam.eu01.nr-data.net/events/1/NRJS-c1e44b406a79b06158d?a=538464022&sa=1&v=1.260.1&t=Unnamed%20Transaction&rst=1775&ck=0&s=e59d79c91b1e4d8a&ref=https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer&ptid=f746a59ef1f55c4b
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
185.221.87.23 , Ireland, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
0c9cf152a0ad00d4f102c93c613c104914be5517ac8f8e0831727f8bfbe8b300

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://dougallmd.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Sun, 02 Jun 2024 12:21:40 GMT
access-control-allow-methods
GET, POST, PUT, HEAD, OPTIONS
content-type
image/gif
access-control-allow-origin
https://dougallmd.com
access-control-allow-credentials
true
Connection
keep-alive
Content-Length
24
x-served-by
cache-fra-etou8220104-FRA
locale-dgpt.json
c-phnx.dougallmd.com/assets/misc/locale/
655 KB
656 KB
XHR
General
Full URL
https://c-phnx.dougallmd.com/assets/misc/locale/locale-dgpt.json
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.10.172 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
51b0f873c5e83109821960fc4fa88dbf6dbfa2187346fddccbc9e54a24fe1020
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Accept
application/json, text/plain, */*
Referer
https://dougallmd.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 12:21:41 GMT
content-encoding
7bit
via
1.1 0e5084c3f3749abdd1195ad293d2faa2.cloudfront.net (CloudFront)
x-amz-version-id
wnPtKIsvGodtWfoSrATLbWghLhlKwdMz
cf-cache-status
DYNAMIC
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
CDG52-P2
age
29586
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
x-amz-storage-class
INTELLIGENT_TIERING
alt-svc
h3=":443"; ma=86400
content-length
670518
last-modified
Wed, 15 May 2024 15:17:29 GMT
server
cloudflare
etag
"423eb6a21230c23b6c28be258abcd605"
access-control-max-age
3000
access-control-allow-methods
GET, HEAD
content-type
application/json
access-control-allow-origin
https://dougallmd.com
access-control-expose-headers
x-amz-server-side-encryption, x-amz-request-id, x-amz-id-2
vary
Accept-Encoding,Origin,Access-Control-Request-Headers,Access-Control-Request-Method
access-control-allow-credentials
true
accept-ranges
bytes
cf-ray
88d767938ead9bb6-FRA
x-amz-cf-id
KvjhezJUn2IQbUHZUIaenjIpIBGciCZx9P29etH-m7jnC3oECmcKVA==
client.js
c-neml.dougallmd.com/device/
43 KB
17 KB
Script
General
Full URL
https://c-neml.dougallmd.com/device/client.js
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:aac , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
263468562ac0f3496f0b7f8860b479f9f49d55e746aa909a47ad1a1e94f9cf62
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://dougallmd.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 12:21:41 GMT
via
1.1 91353a8aba9ab05d79e9678e004043bc.cloudfront.net (CloudFront)
x-content-type-options
nosniff
cf-cache-status
HIT
content-encoding
gzip
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA60-P1
age
12
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
last-modified
Tue, 16 Apr 2024 14:28:29 GMT
server
cloudflare
etag
W/"743b629c2fd75a3bf9d68ff918e30d94"
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=14400
cf-ray
88d76793da2935e1-FRA
x-amz-cf-id
_S1oYNk7qcN-4maIBEs_Ex2JU44rOqiGIZFzk_EoxYEgc99tkHnrhA==
expires
Sun, 02 Jun 2024 16:21:41 GMT
RelevantID4.js
dougallmd.com/prx/rvid/
191 KB
36 KB
XHR
General
Full URL
https://dougallmd.com/prx/rvid/RelevantID4.js
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.10.172 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
cdb617c30321149f35fe4e71ccde5d7a3aaea47d312a7d208b2cb245f46f0cd7
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options DENY

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
tracestate
2926632@nr=0-1-3151430-538464022-3d8151052070261c----1717330901148, 2926632@nr=0-1-3151430-538464022-608afd3daa41b7e3----1717330901148
traceparent
00-28f020de798f7bcf99c11af594529de3-3d8151052070261c-01, 00-4eeb4c40c45946a3e1230cb1424d0ab8-608afd3daa41b7e3-01
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
newrelic
eyJ2IjpbMCwxXSwiZCI6eyJ0eSI6IkJyb3dzZXIiLCJhYyI6IjMxNTE0MzAiLCJhcCI6IjUzODQ2NDAyMiIsImlkIjoiM2Q4MTUxMDUyMDcwMjYxYyIsInRyIjoiMjhmMDIwZGU3OThmN2JjZjk5YzExYWY1OTQ1MjlkZTMiLCJ0aSI6MTcxNzMzMDkwMTE0OCwidGsiOiIyOTI2NjMyIn19, eyJ2IjpbMCwxXSwiZCI6eyJ0eSI6IkJyb3dzZXIiLCJhYyI6IjMxNTE0MzAiLCJhcCI6IjUzODQ2NDAyMiIsImlkIjoiNjA4YWZkM2RhYTQxYjdlMyIsInRyIjoiNGVlYjRjNDBjNDU5NDZhM2UxMjMwY2IxNDI0ZDBhYjgiLCJ0aSI6MTcxNzMzMDkwMTE0OCwidGsiOiIyOTI2NjMyIn19
Accept
application/json, text/plain, */*
Referer
https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 12:21:41 GMT
via
1.1 5317564e96c9dceb46123f6c5f149a02.cloudfront.net (CloudFront), 1.1 d0a36dbd6f5cc87855296f2852cab3ec.cloudfront.net (CloudFront)
content-encoding
gzip
cf-cache-status
REVALIDATED
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA50-C1, FRA60-P7
x-amz-server-side-encryption
AES256
x-cache
Miss from cloudfront
alt-svc
h3=":443"; ma=86400
last-modified
Wed, 03 Apr 2024 13:27:29 GMT
server
cloudflare
etag
W/"ecfcfbb1297ac0d98b5afa9c144995a1"
vary
Accept-Encoding
x-frame-options
DENY
content-type
application/javascript
cache-control
public, max-age=14400
cf-ray
88d767943e9735f3-FRA
x-amz-cf-id
lnyp5TiM2FiGf0PnC3SQZU9xQtCWwPbxtFHX1RgOdAlO4IP1_iJuVQ==
expires
Sun, 02 Jun 2024 16:21:41 GMT
url
phnx.dougallmd.com/v2/fb/search/article/
0
0
Preflight
General
Full URL
https://phnx.dougallmd.com/v2/fb/search/article/url
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.10.172 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
*/*
Access-Control-Request-Headers
authorization,content-type
Access-Control-Request-Method
POST
Origin
https://dougallmd.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

access-control-allow-headers
Content-Type,X-Amz-Date,Authorization,X-Api-Key,X-Amz-Security-Token,X-Amz-User-Agent,X-Amzn-Trace-Id
access-control-allow-methods
OPTIONS,POST
access-control-allow-origin
*
alt-svc
h3=":443"; ma=86400
cf-cache-status
DYNAMIC
cf-ray
88d76794c8929bb6-FRA
content-length
0
content-type
application/json
date
Sun, 02 Jun 2024 12:21:41 GMT
server
cloudflare
strict-transport-security
max-age=31536000; includeSubDomains; preload
via
1.1 debf5a1694fcb96cc13d895660321eda.cloudfront.net (CloudFront), 1.1 0a4e8f7c3d348e526848328c55dd452a.cloudfront.net (CloudFront)
x-amz-apigw-id
YvSJYEygDoEEdhg=
x-amz-cf-id
r663V1yGISYW2kx62lvwXbsjQg-570W-jo38Xm_x85pbi_kawx4Gjw==
x-amz-cf-pop
FRA60-P6 FRA56-C2
x-amzn-requestid
ca34046b-fcf7-473b-84fd-18ed59d9f083
x-cache
Miss from cloudfront
x-content-type-options
nosniff
misc
phnx.dougallmd.com/v2/content/
0
0
Preflight
General
Full URL
https://phnx.dougallmd.com/v2/content/misc
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.10.172 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
*/*
Access-Control-Request-Headers
authorization,content-type
Access-Control-Request-Method
POST
Origin
https://dougallmd.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

access-control-allow-headers
Content-Type,X-Amz-Date,Authorization,X-Api-Key,X-Amz-Security-Token,X-Amz-User-Agent,X-Amzn-Trace-Id
access-control-allow-methods
OPTIONS,POST
access-control-allow-origin
*
alt-svc
h3=":443"; ma=86400
cf-cache-status
DYNAMIC
cf-ray
88d76794c8999bb6-FRA
content-length
0
content-type
application/json
date
Sun, 02 Jun 2024 12:21:41 GMT
server
cloudflare
strict-transport-security
max-age=31536000; includeSubDomains; preload
via
1.1 9d1f21fface75767578955e1853e754e.cloudfront.net (CloudFront), 1.1 8fd360cd20d33fa1400394ae41746f66.cloudfront.net (CloudFront)
x-amz-apigw-id
YvSJYGDHjoEEqOA=
x-amz-cf-id
cDc6iw3-XdaExQKG9MiM7mfUjk09ggyuXoWwtswQe_CuPDHzE9Pd-w==
x-amz-cf-pop
FRA60-P6 FRA56-C2
x-amzn-requestid
86738bb6-069a-415e-9ce3-dc44a6641c60
x-cache
Miss from cloudfront
x-content-type-options
nosniff
misc
phnx.dougallmd.com/v2/content/
0
0
Preflight
General
Full URL
https://phnx.dougallmd.com/v2/content/misc
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.10.172 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept
*/*
Access-Control-Request-Headers
authorization,content-type
Access-Control-Request-Method
POST
Origin
https://dougallmd.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

access-control-allow-headers
Content-Type,X-Amz-Date,Authorization,X-Api-Key,X-Amz-Security-Token,X-Amz-User-Agent,X-Amzn-Trace-Id
access-control-allow-methods
OPTIONS,POST
access-control-allow-origin
*
alt-svc
h3=":443"; ma=86400
cf-cache-status
DYNAMIC
cf-ray
88d76794c89d9bb6-FRA
content-length
0
content-type
application/json
date
Sun, 02 Jun 2024 12:21:41 GMT
server
cloudflare
strict-transport-security
max-age=31536000; includeSubDomains; preload
via
1.1 fca814089bc9a82fba87ce0548f9f358.cloudfront.net (CloudFront), 1.1 cb1bcb02f5d0667fafd0890701965f18.cloudfront.net (CloudFront)
x-amz-apigw-id
YvSJYFJUDoEEU7A=
x-amz-cf-id
YthvJqOAoWwMeET0Q1NYcHInKZvxDpSs0Kw1RRCNT2XnH1jRPx0QAg==
x-amz-cf-pop
FRA60-P6 FRA56-C2
x-amzn-requestid
9a6d250d-9872-43a4-a4dd-43ef300888af
x-cache
Miss from cloudfront
x-content-type-options
nosniff
UcC73FwrK3iLTeHuS_fvQtMwCp50KnMa1ZL7.woff2
fonts.gstatic.com/s/inter/v13/
46 KB
46 KB
Font
General
Full URL
https://fonts.gstatic.com/s/inter/v13/UcC73FwrK3iLTeHuS_fvQtMwCp50KnMa1ZL7.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Inter:400,700
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:827::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
88df0b5a7bc397dbc13a26bb8b3742cc62cd1c9b0dded57da7832416d6f52f42
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://fonts.googleapis.com/
Origin
https://dougallmd.com
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Sat, 01 Jun 2024 01:47:47 GMT
x-content-type-options
nosniff
age
124434
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
46704
x-xss-protection
0
last-modified
Wed, 13 Sep 2023 23:49:07 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 01 Jun 2025 01:47:47 GMT
dougallmd-logo.svg
c-phnx.dougallmd.com/assets/sites/dougallgpt/
10 KB
10 KB
Image
General
Full URL
https://c-phnx.dougallmd.com/assets/sites/dougallgpt/dougallmd-logo.svg
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.10.172 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
0422fb3d56ade626ee2c7ad03240a7fe5aca7d1aa80fd74dedb1cec16793bd2b
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://dougallmd.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 12:21:41 GMT
content-encoding
7bit
via
1.1 3adffce7dd03a16d055927ad5fa7671a.cloudfront.net (CloudFront)
x-amz-version-id
NP_xSMNm1Zo0H.Uua1InU0PHD9Fjz3Nm
cf-cache-status
HIT
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA56-P10
x-amz-server-side-encryption
AES256
x-cache
RefreshHit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
9910
last-modified
Thu, 04 May 2023 16:11:30 GMT
server
cloudflare
etag
"029350809c8aa6ab979e5f15a1accbc4"
vary
Accept-Encoding, Origin
content-type
image/svg+xml
cache-control
public, max-age=14400
accept-ranges
bytes
cf-ray
88d76794bf2a35f3-FRA
x-amz-cf-id
o7Gl2yP_Oynxy2AEW3FtpS1OawMNs0Xp0cf87KMyi548LM-DNCKAag==
expires
Sun, 02 Jun 2024 16:21:41 GMT
url
phnx.dougallmd.com/v2/fb/search/article/
5 KB
3 KB
XHR
General
Full URL
https://phnx.dougallmd.com/v2/fb/search/article/url
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.10.172 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
42cce6ad4e53aec4dcdc27b1d59b5bab4fdb5613976f557e413fd9f8b870e27d
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
Authorization
Bearer eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
Content-Type
application/json
Accept
application/json, text/plain, */*
Referer
https://dougallmd.com/
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 12:21:41 GMT
content-encoding
gzip
via
1.1 75f70026bed8fa7e14f645c02f074728.cloudfront.net (CloudFront), 1.1 3298c44116035984c2fac24b89183c4e.cloudfront.net (CloudFront)
cf-cache-status
DYNAMIC
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA60-P6, FRA56-C2
x-amzn-requestid
6de36e31-b208-4be1-8dfa-0adae178ecb2
x-cache
Miss from cloudfront
x-amz-apigw-id
YvSJZEHSDoEEuUg=
content-length
2159
alt-svc
h3=":443"; ma=86400
server
cloudflare
x-amzn-trace-id
Root=1-665c63d5-62636a8d7e84ae6a314c10a7;Parent=02b9a1075a904b1b;Sampled=0;lineage=03d16b22:0|03f65052:0
content-type
application/json
access-control-allow-origin
*
access-control-allow-credentials
true
cf-ray
88d767959a7a9bb6-FRA
x-amz-cf-id
1ZMJXq5gtO9mNRzYanKBm3jfyxnP1tyNJI1nIfXmPiNXsAQGcHgKiw==
misc
phnx.dougallmd.com/v2/content/
51 KB
20 KB
XHR
General
Full URL
https://phnx.dougallmd.com/v2/content/misc
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.10.172 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
ec490000fb0d17db6839f168bef62c9af02cf7e7b12ba7f9901096318c21b48e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
Authorization
Bearer eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
Content-Type
application/json
Accept
application/json, text/plain, */*
Referer
https://dougallmd.com/
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 12:21:41 GMT
content-encoding
gzip
via
1.1 18fab39b23fb6b3013058d6df5faf0bc.cloudfront.net (CloudFront), 1.1 8fd360cd20d33fa1400394ae41746f66.cloudfront.net (CloudFront)
cf-cache-status
DYNAMIC
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA60-P6, FRA56-C2
x-amzn-requestid
c9f5df6f-01fa-45d0-a47d-733e882f1af9
x-cache
Miss from cloudfront
x-amz-apigw-id
YvSJYGXtjoEERvw=
content-length
19920
alt-svc
h3=":443"; ma=86400
server
cloudflare
x-amzn-trace-id
Root=1-665c63d5-059333c516043cb23b54c6be;Parent=5dfdacf7a675fc33;Sampled=0;lineage=03d16b22:0|accbd57e:0
content-type
application/json
access-control-allow-origin
*
access-control-allow-credentials
true
cf-ray
88d767957a439bb6-FRA
x-amz-cf-id
TXDS9pTjMP4xt7OzZSsTksRoUTjMh7aDd0Tj9iyBGswtFMXGvZz1yw==
misc
phnx.dougallmd.com/v2/content/
52 KB
9 KB
XHR
General
Full URL
https://phnx.dougallmd.com/v2/content/misc
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.10.172 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
d9b7a5cf59c5af6c995821e4a80ef57ab0e69eaf9b7ecc995824b4a33bea9b12
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
Authorization
Bearer eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
Content-Type
application/json
Accept
application/json, text/plain, */*
Referer
https://dougallmd.com/
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 12:21:41 GMT
content-encoding
gzip
via
1.1 cbd5498107be7e5bcccda272c5fdbef4.cloudfront.net (CloudFront), 1.1 cb1bcb02f5d0667fafd0890701965f18.cloudfront.net (CloudFront)
cf-cache-status
DYNAMIC
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
FRA60-P6, FRA56-C2
x-amzn-requestid
2ec28287-5201-46a7-ae7b-200282b6b4ca
x-cache
Miss from cloudfront
x-amz-apigw-id
YvSJZH7djoEEuGw=
content-length
8141
alt-svc
h3=":443"; ma=86400
server
cloudflare
x-amzn-trace-id
Root=1-665c63d5-767fdebd3a13468f0065c523;Parent=3f3db3422bf3f4d9;Sampled=0;lineage=03d16b22:0|accbd57e:0
content-type
application/json
access-control-allow-origin
*
access-control-allow-credentials
true
cf-ray
88d767959a769bb6-FRA
x-amz-cf-id
tBMqwJE3aWSwwhrCu5NOLMgwMELZBWGvbGrbw6nvarA1rEwgtstK0Q==
dedupe
rvid.imperium.com/
0
0
Preflight
General
Full URL
https://rvid.imperium.com/dedupe
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.205.46.52 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-205-46-52.compute-1.amazonaws.com
Software
Kestrel /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type,x-clientid
Access-Control-Request-Method
POST
Origin
https://dougallmd.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

access-control-allow-headers
content-type,x-clientid
access-control-allow-methods
POST
access-control-allow-origin
*
date
Sun, 02 Jun 2024 12:21:41 GMT
server
Kestrel
dedupe
rvid.imperium.com/
2 KB
2 KB
XHR
General
Full URL
https://rvid.imperium.com/dedupe
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.205.46.52 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-205-46-52.compute-1.amazonaws.com
Software
Kestrel /
Resource Hash
5bde473f6b6477b77f8f123e06661000d15ca407d33b062e1a50bc9598facca8

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
X-ClientID
BC170856-91EA-11ED-A210-1264B5C78F33
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
Content-Type
application/json
Referer
https://dougallmd.com/
sec-ch-ua-platform
"Win32"

Response headers

access-control-allow-origin
*
date
Sun, 02 Jun 2024 12:21:41 GMT
server
Kestrel
content-length
2083
content-type
application/json; charset=utf-8
rvid
api.neml.io/device/
51 B
828 B
XHR
General
Full URL
https://api.neml.io/device/rvid
Requested by
Host: dougallmd.com
URL: https://dougallmd.com/article/eftilagimod-improves-efficacy-of-pembrolizumab-in-first-line-treatment-of-non-small-cell-lung-cancer?interactionId=DDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D&dp=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzaXRlSWQiOjUzMCwiaW5mb0lkIjoiNTI5LTEwMTM2NDQ2OS1jMmE1NWJiMS0xNzE3MDkyMjQ2OTYyIiwicm9sZUlkIjoic29mdCIsInV1aWQiOiI1MzAtOWQ1MjgwNzYtOWQzMy00Y2VlLThiYWMtNmRlNDQzNmJlNWQ4IiwicGFydHlJZCI6MTAxMzY0NDY5LCJ0eXBlIjoiYWNjZXNzIiwiZG9tYWluIjoiZG91Z2FsbG1kLmNvbSIsImlzc3VlciI6InBob2VuaXgiLCJpYXQiOjE3MTczMzA4OTksImV4cCI6MTcxOTkyMjg5OX0.Je1FSo0f8vIePU4xTRkxNdMBOPhVeEJQgjC6xRgEa5c&article_id=5676151&article_title=Eftilagimod+Improves+Efficacy+of+Pembrolizumab+in+First-Line+Treatment+of+Non-Small-Cell+Lung+Cancer&source=dougallgpt
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
108.138.36.76 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-108-138-36-76.muc50.r.cloudfront.net
Software
/
Resource Hash
93d2b99e24a340b98641bccba013e67490d3557bee217feb8cc68b76a0103391
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
Content-Type
text/plain
Accept
application/json, text/plain, */*
Referer
https://dougallmd.com/
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 02 Jun 2024 12:21:42 GMT
content-encoding
gzip
via
1.1 e6ecdd688219ba98d4d4d70abc494a54.cloudfront.net (CloudFront), 1.1 c7e33a86531bfe239a9c43428fc5c122.cloudfront.net (CloudFront)
x-content-type-options
nosniff
strict-transport-security
max-age=31536000
x-amz-cf-pop
MUC50-P5, MUC50-P2
x-amzn-requestid
eca49c4e-3232-40b6-9ca5-4c879e65c905
x-cache
Miss from cloudfront
x-amz-apigw-id
YvSJeE8hjoEEWpA=
content-length
71
x-xss-protection
1; mode=block
referrer-policy
strict-origin-when-cross-origin
x-amzn-trace-id
Root=1-665c63d5-6343f8f93e59cb4e49d1a694;Parent=72148911d0c6c71f;Sampled=0;lineage=b9d4f140:0
vary
Origin
access-control-allow-methods
POST, OPTIONS
content-type
application/json
access-control-allow-origin
https://dougallmd.com
x-frame-options
SAMEORIGIN
access-control-allow-credentials
true
access-control-allow-headers
*, Content-Type, Authorization
x-amz-cf-id
eK701zZ45AoaJyAVHShiu1rg3lfjDUSTUE8stJP9AkpLSplsdRUFaA==
dgan
api.phnxml.io/v2/content/
Redirect Chain
  • https://p-dgan.dougallmd.com/dgan/bserverj/b1/hint=x/DSPID=/property=dougallmd/mid=101364469/emailid=7651829/personid=101364469/channel=website/size=520x150/geography=be/prof=12/spec=55/viewid=1013...
  • https://api.phnxml.io/v2/content/dgan?originalQueryString=&requestId=5c044kjB-rDroeCFN3LG6SxZm5poEqBcB1n97yFYj4iVTw7SPEuLUA%3D%3D&requestPath=%2Fdgan%2Fbserverj%2Fb1%2Fhint%3Dx%2FDSPID%3D%2Fpropert...
0
0

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain
api.phnxml.io
URL
https://api.phnxml.io/v2/content/dgan?originalQueryString=&requestId=5c044kjB-rDroeCFN3LG6SxZm5poEqBcB1n97yFYj4iVTw7SPEuLUA%3D%3D&requestPath=%2Fdgan%2Fbserverj%2Fb1%2Fhint%3Dx%2FDSPID%3D%2Fproperty%3Ddougallmd%2Fmid%3D101364469%2Femailid%3D7651829%2Fpersonid%3D101364469%2Fchannel%3Dwebsite%2Fsize%3D520x150%2Fgeography%3Dbe%2Fprof%3D12%2Fspec%3D55%2Fviewid%3D1013644695301717330901193%2Frandom%3D19908%2Fpid%3D29908%2FCampaignID%3D1%2FinteractionId%3DDDfHRuHnt2FiEoLnTOICXDrkg2ic6dU5EBrw9sgsW2mKwQ3orMepFA%3D%3D%2Fzone%3Darticlepage%2Ftags%3DCND3843%2CCND0396%2CCND2861%2CCND4281%2CCND2061%2CCND4356%2CCND3665%2CCND5557%2CCND6427%2CDRG07177%2CDRG10740%2CDRG04819&timestamp=1717330901982&referer=https%3A%2F%2Fdougallmd.com%2F&userAgent=Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36

Verdicts & Comments Add Verdict or Comment

183 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| NREUM object| newrelic function| __nr_require object| SASIA boolean| SASIA_VIEWTRACKER_DEBUG boolean| SASIA_VIEWTRACKER_ALLOW_BLURRED object| webpackChunkcra_template function| clearImmediate function| setImmediate function| _ object| userflow object| USERFLOWJS_QUEUE object| di object| _paq object| webpackChunk:NRBA-1.260.1.PROD object| Piwik object| Matomo object| AnalyticsTracker function| piwik_log object| NEML object| RVIDPrivacy string| _RVIDCaptureString object| _extraDataPoints string| _version object| captureObject string| __xe1913148__ number| _hpd object| PluginDetect string| userAgent boolean| isIE boolean| isWin boolean| isMac boolean| is_iPhone boolean| is_iPod boolean| isLinux boolean| isAndroid boolean| isOpera boolean| isChrome boolean| isSafari boolean| isFF boolean| isAOL number| counter object| body1 number| jsver object| BrowserDetect string| propertyString1 object| RVIDFlash string| hasRIF function| sha256 string| imperiumOriginalSurvey string| imperiumOriginalCookie function| sendLogMessageAsync function| createRVIDXMLHttpRequest function| setHoPoDetection function| tochar function| rvidPing function| setRVIDDataReadyAndSubmitForm function| callRVIDNow function| addValue function| addCapValue function| getOS function| checkIframes function| getSilverlightVersion function| getSilverlightMajorVersion function| detectSilverlight function| detectDirector function| getDirectorVersion function| getWindowsMediaVersion function| detectWindowsMedia function| isFlip4MacInstalled function| Flip4MacVersion function| getFlashInfo function| canDetectNavigatorPlugins function| detectPlugin function| getAllPlugins function| createScriptTag function| getJavascriptVersion function| BrowserInfo function| Get_Cookie function| Set_Cookie function| GetFontSize function| getTimeZoneDiff function| getJavaScriptBuild function| getBrowserBuild function| getNetMeetingBuild function| getServicePack function| getUserLanguage function| getSystemLanguage function| detectGecko function| getGeckoBuildDateToInt function| getConnectionType function| supportsDHTML function| supportsXMLHttpRequest function| supportsXML function| getAolVersion function| isEmailCrawler function| canUploadFile function| persistentCookies function| sessionCookies function| ExpireCookie_ function| addToCapture function| getBrowserTime function| getBrowserTimeMS function| getJavaEnabled function| getDataPoints function| rvidFreezeSetProp function| AddScriptTag function| checkTime function| checkTimeTime function| getDateTime function| createDiv function| createSol function| writeRIF function| setRIF1 function| setRIF2 function| getRIF1 function| readRIF function| rifStatusCheck function| createField function| createRVIDField function| createOutputFields function| getScore function| IsPageTranslated function| executeService function| isPropStringValid function| LogWarningForAnyMissingRequestPars function| LogWarningForMissingRequestPar function| getFunctionHash function| ImperiumXhrPost function| ImperiumGetValue function| isSSLv3MigratedClient function| getCNprintLegacyHash function| getCNprintLegacy function| getCNprintHash function| getWebGLRenderer function| getWebGLDataHash function| Get_CookieRIF3 function| Set_CookieRIF3 function| Expire_CookieRIF3 function| setRIF3 function| getRIF3 function| isMobile function| isMobile1 function| inIframe function| featDetectBrowser function| _pluginContains function| checkForAutomatedBrowserProps function| notificationPermissions function| isNotificationPermissionsOverridden function| keyboardLayoutMapSize function| mediaDevicesConstraintsCount function| _supportsBluetooth function| storageManagerDetails function| _userAgentClientHints function| _accelDetect function| _gyroDetect function| getAudioSampleRate function| mediaDeviceGroups function| _detectPrivacyMode function| getAllMimeTypes function| rvidDevToolsOpen object| relevantID object| jstz number| RVIDTrack string| RVIDClientID object| C object| ZZZ object| MobileOSArray object| MobileType object| isThisMobile object| browserobject number| pluginsArrayCounter number| namesCounter object| ma number| RVIDReady function| RVIDResponseComplete function| getScoreAdditional object| start1 object| start2 number| rifFlag object| start4 number| k function| matomoMediaAnalyticsAsyncInit

7 Cookies

Domain/Path Name / Value
dougallmd.com/article Name: RVIDExtId
Value: 9D4CB8AE-C130-4587-B438-BF79429CAAE5
dougallgpt.com/ Name: _pk_id.150.0e10
Value: ff7fcd182abe26b1.1717330899.
dougallgpt.com/ Name: _pk_ses.150.0e10
Value: 1
dougallgpt.com/ Name: _pk_id.146.0e10
Value: 7fd1862a27cd5da5.1717330899.
.dougallgpt.com/ Name: __cf_bm
Value: OBM1lwHcNKxgefXt6c7GlUDJrVW_b_QDPh9B10VpfSk-1717330898-1.0.1.1-6Q4KmstVJKaCGCUetGotUy4.0tz6lswNSSgsurkuXXo3O9k4G41TuubsZsL5oWT4hNwkWjoX5NVNW.sJnBU02g
dougallgpt.com/ Name: RVIDExtId
Value: 9D4CB8AE-C130-4587-B438-BF79429CAAE5
.dougallmd.com/ Name: __cf_bm
Value: sFPgNx4sFo9fDZUOzl17zrhGxNH.nvyIalpFl3LT1H4-1717330901-1.0.1.1-_KOVsV2DqiUJyJgJEQN5S7PjbXXpCeI1AaYSoYOFNpmwkYxh7Ffsq6mDxSXFU.zTTernZH3.m3NXPRP6fShg5Q

2 Console Messages

Source Level URL
Text
other warning (Line 4811)
Message:
The AudioContext was not allowed to start. It must be resumed (or created) after a user gesture on the page. https://goo.gl/7K7WLu
other warning (Line 4811)
Message:
The AudioContext was not allowed to start. It must be resumed (or created) after a user gesture on the page. https://goo.gl/7K7WLu

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options DENY

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

a.dougallgpt.com
a.dougallmd.com
api.neml.io
api.phnxml.io
bam.eu01.nr-data.net
c-neml.dougallgpt.com
c-neml.dougallmd.com
c-phnx.dougallgpt.com
c-phnx.dougallmd.com
content.aimatch.com
dougallgpt.com
dougallmd.com
fonts.googleapis.com
fonts.gstatic.com
js-agent.newrelic.com
phnx.dougallgpt.com
phnx.dougallmd.com
rvid.imperium.com
api.phnxml.io
104.18.10.172
104.18.18.240
104.18.19.240
108.138.36.76
185.221.87.23
2.17.147.219
2600:9000:211e:f200:f:e0ca:fec0:93a1
2602:816:5001::39
2606:4700::6812:12f0
2606:4700::6812:aac
2606:4700::6812:bac
2a00:1450:4001:812::200a
2a00:1450:4001:827::2003
52.205.46.52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